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Acute ischemic stroke is the third leading cause of death and leading cause of disability 
in developed countries. An ischemic stroke results when there is an obstruction of the blood 
supply to the brain. When a patient presents with acute ischemic stroke in the emergency room, 
the first decision that needs to be made is whether or not the patient is a suitable candidate for 
thrombolytic treatment, which can be risky and lead to death. Currently, doctors use a 
combination of multiple magnetic resonance imaging (MRI) scans to determine whether or not a 
patient is suitable for thrombolytic treatment. The combination of diffusion and perfusion scans 
allow doctors to see regions of the brain that have already infarcted and regions at risk of 
infarction. However, perfusion scans frequently overestimate the tissue at risk of infarction, 
which results in stroke patients being taken in for aggressive therapies that they may not benefit 
from. In this dissertation, I explored three ways to improve the current state of diagnostic stroke 
imaging by allowing for better visualization of regions at risk of infarction and by doing this 
non-invasively. 
Upon lack of oxygen delivery to the brain, autoregulatory mechanisms lead to 
vasodilatation of cerebral blood vessels. After blood vessels vasodilatate for an extended time, 
cerebral blood vessels eventually collapse, and the region of tissue supplied by these vessels 
progress to infarction. I hypothesized that regions of the brain with increased cerebral blood 
volume (as a result of vasodilatation) could be salvageable with thrombolytic therapy. To image 
these regions, I scanned eighteen patients using Vascular Space Occupancy (VASO) MRI, a new 
method sensitive to changes in cerebral blood volume. While VASO MRI can provide a different 
type of contrast and potentially offers information that is not available through diffusion and 
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perfusion scans, it is cumbersome to process VASO images, and VASO MRI can be confounded 
by changes in T1 especially if tissue has already progressed to infarction.  
Recent research has shown that pH is a better indicator of regions of the brain at risk of 
irreversible damage. Chemical exchange saturation transfer (CEST) MRI is a novel MRI method 
that is sensitive changes in the exchange rate between bulk water and exchangeable protons on 
proteins. Amide proton transfer (APT) MRI is a subset of CEST-based techniques that is 
sensitive to changes in pH. I scanned healthy volunteers and acute stroke patients with APT MRI. 
I showed that APT MRI has the potential to accurately determine whether or not a region of 
tissue is at risk of infarction.  
It has also been shown that changes in the oxygen extraction fraction, the percentage of 
available oxygen extracted by the brain from the blood, is also a useful indicator when making 
decisions about unique treatment plans for each patient. Hemoglobin, the protein responsible for 
transporting oxygen to all parts of the body, exists in two different states (oxyhemoglobin and 
deoxyhemoglobin), each with exchangeable protons in different parts of the spectrum. By 
applying CEST and frequency label exchange (FLEX) transfer MRI in bovine blood, I detected 
differences in the oxygenation of hemoglobin.  
The work completed in this dissertation has the potential to aid physicians in treatment 
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Chapter 1. Introduction and Overview 
 
1.1 Introduction 
 Management of acute ischemic cerebrovascular syndrome (AICS), more commonly 
known as acute ischemic stroke, is complicated by the heterogeneity of the disease, by the 
need to make fast individualized decisions on a per patient basis, and by deleterious side 
effects of aggressive treatments. Magnetic resonance imaging (MRI) is an emerging form of 
diagnostic imaging with the potential of deriving many new contrast mechanisms by 
manipulating the timing of radiofrequency and magnetic field gradient pulses. Three-
dimensional images can be acquired quickly, non-invasively, with high spatial resolution, 
and without delivering ionizing radiation to the patient.  
 In acute ischemic stroke, an embolus or thrombus obstructs blood flow to certain 
regions of the brain and reduces cerebral perfusion, needed for delivery of oxygen to the 
brain. This results in a “core” region of the brain (where neurons cannot survive due to the 
lack of oxygen) that progresses to infarction (in other words, dies) and is unsalvageable with 
any treatment. However, a few decades ago it was found using Positron Emission 
Tomography (an imaging modality that measures cerebral metabolism and perfusion using 
radiotracers injected into the bloodstream) that regions of the brain surrounding the core that 
have low perfusion and are electrically inactive but are not yet irreversibly damaged can be 
salvaged with thrombolytic therapy. This salvageable region of the brain has been termed the 
“ischemic penumbra”. More recently, the original definition of penumbra has been somewhat 
modified in that the complete region of reduced perfusion surrounding the core has been 
included, which generally is larger than just electrically dysfunctional tissue, Depending on 
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the type of imaging used, multiple penumbra (perfusion-based, pH-based, oxygen extraction 
based) have been defined in an attempt to guide therapy of ischemic stroke patients. There 
are currently three main therapeutic options available to restore blood flow to the brain: 1) 
intravenous tissue plasminogen activator (IV-tPA); 2) intra-arterial tPA (IA-tPA); and 3) 
mechanical thrombectomy (clot retraction). Each therapeutic option carries its own benefits 
and risks, while neurologists frequently have to use incomplete diagnostic information to 
make a decision to treat or not, and which therapy to use. Current MR methodologies focus 
on perfusion deficits and frequently overestimate the ischemic penumbra, which results in 
patients being taken for aggressive therapy and being exposed to unnecessary risks. This 
dissertation is written with the long-term goal of advancing the field of diagnostic stroke 
imaging with the development and application of novel MRI contrast mechanisms to image 
the ischemic penumbra in AICS patients.  
 
1.2. Overview 
This dissertation is organized in the following way. First, the reader is given an 
introduction into the physical mechanisms of nuclear magnetic resonance (Chapter 2). Next, 
the reader is introduced to blood (and its components) and how blood delivers oxygen to the 
rest of the body to maintain aerobic metabolism (Chapter 3). Following this, the reader is 
introduced to acute ischemic stroke, a particular pathology where oxygen delivery is 
disrupted due to vessel blockage and, depending on the level of disruption, causes a cascade 
of changes in the human brain (Chapter 4). Next, Chapter 5 presents the work done on 
optimizing Vascular Space Occupancy (VASO) MRI, a cerebral blood volume sensitive 
method, to image the ischemic penumbra based on changes in cerebral blood volume during 
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ischemia. After seeing interesting results using VASO, we decided to image tissue pH, a 
parameter that should be a better indicator of tissue at risk, as it is only changed when 
anaerobic metabolism starts to occur. Results of optimizing the pulse sequence, testing on 
healthy volunteers, and applying the pulse sequence to image intracellular pH in acute 
ischemic stroke patients are presented in Chapter 6. Then, preliminary data from a novel 
idea to use signals of exchangeable protons on hemoglobin proteins in blood to measure 
oxygenation are presented in Chapter 7. Finally, Chapter 8 summarizes the work and 




Chapter 2. Basic Principles of Magnetic Resonance Imaging 
 
2.1. Chapter Goal 
 This chapter introduces the reader to fundamental concepts of magnetic resonance 
imaging (MRI). Because this dissertation is focused on the optimization and development of 
novel magnetic resonance imaging techniques, it is important to have a fundamental 
understanding of how the MRI machine generates images.  
“Magnetic resonance imaging is actually nuclear magnetic resonance imaging, but 
scientists in the field removed the term “nuclear” from the name because at the time, the 
general public had a fear of the term nuclear.” 
- Peter van Zijl, from multiple introductory lectures on MRI methods 
 
2.2. Quantum Mechanical Description of Nuclear Magnetic Resonance (NMR) 
Nuclei have four unique properties: mass, electric charge, magnetism, and 
spin. Spin is a form of angular momentum that is intrinsic to the nucleus. Due to the 
broad scope of this topic, we will limit discussion to hydrogen nuclei, the most 
commonly studied nuclei in NMR. It is a spin-1/2 particle. When it is placed in a 
large external magnetic field, it becomes quantized to two states (mz = +1/2 and mz = 
-1/2) only due to the interaction between the magnetic moment and the field. The 
energy difference between these two states is described by equation 2.1.  
∆𝐸 = 𝛾𝐻ℏ𝐵0        (Equation 2.1) 
 Where γH is 267.522x106 rad/(T∙s) and represents the gyromagnetic ratio (the 
ratio of magnetic moment of the nucleus and its angular momentum) of hydrogen; ħ 
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is Plank’s constant (6.626068 × 10-34 m2 kg / s) divided by 2π; and B0 represents the 
large external magnetic field and has units of Tesla (T). The energy difference is 
related to the frequency of precession through the following relationship: ΔE=ħω.  
𝜔0 = 𝛾𝐻𝐵0         (Equation 2.2) 
This frequency, ω0 (rad/s), is known as the Larmor frequency. 
 
Figure 2.1. A hydrogen nuclei precesses at the Larmor frequency, proportional to the 
large external magnetic field it is placed in. 
When a group of spin-1/2 is placed in a magnetic field, every spin aligns in 
one of two directions: with the magnetic field (lower energy) or against the magnetic 
field (higher energy). This is known as the Zeeman effect (figure 2.2).  
 
Figure 2.2. Distribution of spins aligning with and against B0. 
The Boltzmann distribution (equation 2.2) relates the ratio of spins in the two 
energy levels to the difference in energy between the two levels. 
𝑁𝛼
𝑁𝛽
= 𝑒−ΔE kbT⁄        (Equation 2.2) 
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Nα and Nβ represent the number of spins in the lower and higher energy states, 
respectively. ΔE is the energy difference between the two energy states (equation 2.1), 
kb is the Boltzmann constant, 1.381x10-23 
𝑚2𝑘𝑔
𝑠2𝐾
, and T is the absolute temperature in 
Kelvin (K).  
When a sample is placed in a large magnetic field (B0), the difference between 
the two energy states (with and against the magnetic field) forms the longitudinal 
magnetization vector with which we can use the classical description of NMR to 
continue our discussion. 
 
2.3. Relaxation (Spin-Lattice (T1), Spin-Spin (T2), and 𝐓𝟐∗ Relaxation Mechanisms)  
Before continuing with the classical description of NMR, we offer an 
introduction to relaxation mechanisms which is necessary before we continue. When 
a sample is rapidly brought into the presence of a large magnetic field, the rate at 
which the longitudinal magnetization vector forms is in the form of an exponential 
function: 
𝑀𝑧(𝑡) = 𝑀0(1 − 𝑒
−(𝑡−𝑡𝑜𝑛)
𝑇1� )       (Equation 2.3) 
Similarly, if the sample is rapidly brought out of the presence of a large magnetic 
field, the decay is also an exponential function of the form:  




        (Equation 2.4) 




Figure 2.3. Buildup and decay of longitudinal spin magnetization. Reproduced with 
permission from (1). 
Another relaxation mechanism that is important when studying NMR is the 
transverse relaxation rate, or T2. When a spin ensemble is placed onto the transverse 
plane (x-y plane) using a radiofrequency pulse, the magnetization vector begins to 
dephase as shown in figure 2.5. The rate at which this dephasing occurs is the 
transverse relaxation time. This decay is governed by equation 2.5.  
𝑀𝑥𝑦(𝑡) = 𝑀𝑥𝑦(0)𝑒
−𝑡 𝑇2�         (Equation 2.5) 
 
Figure 2.4. Dephasing of the magnetization vector when tipped onto 
transverse plane using a 90° radiofrequency pulse. 
However, pure transverse (T2) decay is only from the completely random 
interactions between spins, which requires a completely homogeneous main magnetic 
field. In reality, there are inhomogeneities in the main magnetic field and 
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susceptibility differences in the sample that cause transverse magnetization to decay 





+ 𝛾∆𝐵𝑖𝑛ℎ𝑜𝑚𝑜𝑔𝑒𝑛𝑒𝑖𝑡𝑖𝑒𝑠      (Equation 2.6) 
 
2.4. The Classical Description of NMR: Bloch Equations  
 2.4.1. Basic Bloch Equations 
Being able to treat the combined behavior of all of the spins in the system as a 
magnetization vector allows the use of a classical description to give a simpler picture 
of an NMR experiment via the Bloch Equation (2): 
 ?̇?(𝑡) = 𝛾𝑴(𝑡) × 𝑩(𝑡)           (Equation 2.7) 
When analyzing the Bloch equation in the orthogonal components, the Bloch 

















        (Equation 2.10) 
These Bloch equations can be solved for the magnetization evolution and 
relaxation to yield: 
 𝑀𝑥(𝑡) = 𝑒
−𝑡
𝑇2� (𝑀𝑥(0) cos𝜔0𝑡 + 𝑀𝑦(0) sin𝜔0𝑡)    (Equation 2.11) 
𝑀𝑦(𝑡) = 𝑒
−𝑡
𝑇2� (𝑀𝑦(0) cos𝜔0𝑡 − 𝑀𝑥(0) sin𝜔0𝑡)    (Equation 2.12) 
𝑀𝑧(𝑡) = 𝑀𝑧(0)𝑒
−𝑡
𝑇1� + 𝑀0(1 − 𝑒
−𝑡
𝑇1� )      (Equation 2.13) 
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In order to detect any signal from an NMR experiment, a radiofrequency (RF) 
field must be used to tip the magnetization onto the transverse plane. We can model 
this in the rotating frame (rotation speed omega) as: 
𝐵�⃗ 𝑒𝑓𝑓 = �𝐵0 −
𝜔
𝛾
� ?̂? + 𝐵1𝑥�′        (Equation 2.14) 












        (Equation 2.16) 
𝑑𝑀𝑦
𝑑𝑡
= −∆𝜔𝑀𝑥 + 𝜔1𝑀𝑧 −
𝑀𝑦
𝑇2
      (Equation 2.17) 
Where Δω = ω0 – ω, and the solution to this set of differential equations is: 
𝑀𝑥(𝑡) = 𝑒−𝑡 𝑇2⁄ (𝑀𝑥(0) cos∆𝜔𝑡 +  𝑀𝑦 sin∆𝜔𝑡)    (Equation 2.18) 
𝑀𝑦(𝑡) = 𝑒−𝑡 𝑇2⁄ (𝑀𝑦(0) cos∆𝜔𝑡 −  𝑀𝑥 sin∆𝜔𝑡)    (Equation 2.19) 
𝑀𝑧(𝑡) = 𝑀𝑧(0)𝑒−𝑡 𝑇1⁄ + 𝑀0(1 − 𝑒−𝑡 𝑇1⁄ )     (Equation 2.20) 
 
2.5. Chemical Exchange: Bloch-McConnell Equations 
 A unique feature of NMR is its ability to measure chemical exchange, for instance 
such as it is occurring between -OH, -NH, and -SH groups and the solvent water. For two 
exchange sites (otherwise known as a two-pool model), we begin with the simple system 




Where kSW is the rate constant for exchange from pool S to pool W and kWS is the rate 
constant for exchange from pool W to pool S. The concentrations of S and W can be related 
to the rate constants through the following equations: 
𝑑[𝑆]
𝑑𝑡
= −𝑘𝑠𝑤[𝑆] + 𝑘𝑤𝑠[𝑊]        (Equation 2.21) 
𝑑[𝑊]
𝑑𝑡
= 𝑘𝑠𝑤[𝑆] − 𝑘𝑤𝑠[𝑊]        (Equation 2.22) 
 This is intuitive in that the differential concentration of pool S will be increased by 
the amount of molecules from pool W exchanged to pool S (given by the product of rate of 
exchange from pool W to pool S times the concentration of pool W) and decreased by the 
amount of molecules from pool S exchanged to W, and similarly for the differential 
concentration of pool W.  
To describe chemical exchange in a spin system, we need to convert these 
concentration-based equations to reflect the magnetization of these two pools in order to add 
them to the Bloch equations. The equilibrium magnetization of pools S and W are directly 
proportional to the concentrations of pools S and W, therefore, equations 2.21 and 2.22 can 
be written to describe the effect of exchange on the magnetization of pool s and pool W. The 
chemical exchange modified Bloch equations are known as Bloch-McConnell equations 
named after Harden McConnell who derived them in 1958 and are given in equations 2.23-
2.28 (3):    
𝑑𝑀𝑥𝑠
𝑑𝑡
= −∆𝜔𝑠𝑀𝑦𝑠 − 𝑅2𝑠𝑀𝑥𝑠 − 𝑘𝑠𝑤𝑀𝑥𝑠 + 𝑘𝑤𝑠𝑀𝑥𝑤     (Equation 2.23) 
𝑑𝑀𝑦𝑠
𝑑𝑡
= ∆𝜔𝑠𝑀𝑥𝑠 + 𝜔1𝑀𝑧𝑠 − 𝑅2𝑠𝑀𝑦𝑠 − 𝑘𝑠𝑤𝑀𝑦𝑠 + 𝑘𝑤𝑠𝑀𝑦𝑤    (Equation 2.24) 
𝑑𝑀𝑧𝑠
𝑑𝑡
= −𝜔1𝑀𝑦𝑠 − 𝑅1𝑠(𝑀𝑧𝑠 − 𝑀0𝑠) − 𝑘𝑠𝑤𝑀𝑧𝑠 + 𝑘𝑤𝑠𝑀𝑧𝑤    (Equation 2.25) 
𝑑𝑀𝑥𝑤
𝑑𝑡





= ∆𝜔𝑤𝑀𝑥𝑤 + 𝜔1𝑀𝑧𝑤 − 𝑅2𝑤𝑀𝑦𝑤 + 𝑘𝑠𝑤𝑀𝑦𝑠 − 𝑘𝑤𝑠𝑀𝑦𝑤   (Equation 2.27) 
𝑑𝑀𝑧𝑤
𝑑𝑡
= −𝜔1𝑀𝑦𝑤 − 𝑅1𝑤(𝑀𝑧𝑤 −𝑀0𝑤) + 𝑘𝑠𝑤𝑀𝑧𝑠 − 𝑘𝑠𝑤𝑀𝑧𝑤  (Equation 2.28) 
Where R1 and R2 are the longitudinal and transverse relaxation rates, M0 is the 
equilibrium magnetization, and ksw and kws are the exchange rates of protons from pool s to w 
and vice versa. Under equilibrium, the system obeys the relationship:  
𝑘𝑠𝑤𝑀0𝑠 = 𝑘𝑤𝑠𝑀0𝑤         (Equation 2.29) 
 
2.6. Spatial Encoding, Signal Detection, and Imaging Pulse Sequences 
 2.6.1. Spatial Encoding 
The measurement of the precessional frequency of the longitudinal 
magnetization gives information about the magnetic field experienced by any 
ensemble of spins. If the magnetic field is varied in a controlled manner, the 
frequency information can yield spatial information. To demonstrate this principle, 
let’s take the main magnetic field and add a gradient in the z-direction (Gz). Then in 
the z-direction, the field becomes: 
𝐵𝑧(𝑧, 𝑡) = 𝐵0 + 𝑧𝐺(𝑡)      (Equation 2.30) 
 The deviation from the Larmor frequency becomes linear in both z and G and 
can be quantified using the following equation: 
𝜔𝐺(𝑧, 𝑡) = 𝛾𝑧𝐺(𝑡)       (Equation 2.31) 
This relationship allows us to perform frequency encoding of spatial 
information using gradients along the z-axis and leads us to the commonly known 1D 
imaging equation that defines the signal s as a function of frequency. 
𝑠(𝑘) = ∫𝑑𝑧𝜌(𝑧)𝑒−𝑖2𝜋𝑘𝑧         (Equation 2.32) 
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Where ρ(z) is the spin density as a function of position along the z-axis and is 
being integrated over that dimension. However, for imaging in vivo systems, we need 
to encode a 3D volume. For a sample being excited with a set of three orthogonal 
gradients, we can extend the 1D imaging equation to the following (2):  
 𝑠�𝑘�⃗ � = ∭𝑑𝑥 𝑑𝑦 𝑑𝑧 𝜌(𝑥, 𝑦, 𝑧)𝑒−𝑖2𝜋�𝑘𝑥𝑥+𝑘𝑦𝑦+𝑘𝑧𝑧� 
= ∫𝑑3𝑟𝜌(𝑟)𝑒−𝑖2𝜋𝑘�⃗ ∙𝑟        (Equation 2.33)   
Another way to think about slice selection and spatial encoding is to consider 
a sample in a large magnetic field, B0. This sample has a Larmor frequency of γB0. 
When a small linear gradient is added in the z-direction, there is spatial variation of 
frequencies in the z-direction. Spins on one end will precess at a faster frequency than 
spins on the other end. A radiofrequency pulse can be used to selectively excite a 
region of spins (i.e. where the precessing frequency is equal to γB0), determined by 
the Fourier transform of the radiofrequency pulse. The thickness of the slice is then 
determined by the strength of the gradient (figure 2.5). A thicker slice can be selected 
with a smaller gradient (this way a larger region will have spins precessing with 
frequency γB0), and a thinner slice can be selected with a larger gradient (the spatial 
variation of frequencies is larger so a smaller region will have spins precessing with 
frequency γB0). Now that a slice has been selected (z-direction), encoding needs to be 
performed in the x-y plane to resolve in-plane features. Gradients can be turned on in 
the x-direction to perform frequency encoding, which is used to resolve features in 
the left right direction. This is known as frequency encoding because similar to slice 
selection where a gradient is turned on to modulate frequency with respect to position 
along the z-axis, the x-direction gradient is also used to modulate frequency in the x 
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direction. Y-direction encoding is done by modulating the phase of the signal (known 
as phase encoding). The phase encoding gradient is “stepped” during the acquisition 
of a slice. Combined together, slice select, frequency encoding, and phase encoding 
gradients allow MRI to resolve samples in three dimensions. 
 
Figure 2.5. Spatial selection in MRI using slice select (z-direction), frequency encode 
(x-direction), and phase encode (y-direction) gradients. 
 
2.6.2. Detection of Signal 
To detect the NMR signal, an RF coil must be placed in the transverse plane, 
perpendicular to the main magnetic field (B0), where an electric magnetic force (emf) 
is induced that is proportional to the magnetization. The signal from the coil is 
measured using phase sensitive detection, which records the signal on two axes, 
providing real and imaginary components. 
 
 2.6.3. Gradient Echo Imaging Pulse Sequence 
A gradient echo sequence is one of the most common MR sequences used to 
acquire an image. In gradient echo imaging (see figure 2.7), a single RF pulse with 
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flip angle α (where α ≤ 90°) is applied to tip the magnetization onto t he transverse 
plane then a readout gradient reversal scheme with a net zero gradient integral at the 
echo time is used to refocus the echo. In gradient echo imaging, magnetic field 
inhomogeneities and susceptibility differences are not refocused and affect the 
imaging contrast. Therefore, it is important to have a homogeneous magnetic field 
when using GRE imaging. The flip angle (α) can be set to give optimized SNR using 
the Ernst flip angle equation:  
𝛼 = 𝑐𝑜𝑠−1(𝑒−𝑇𝑅 𝑇1⁄ )        (Equation 2.34) 
Where TR is the given repetition time, T1 is the longitudinal relaxation time of 
the tissue being imaged, and α is the optimal flip angle. One way to accelerate GRE 
imaging is with an echo planar imaging (EPI) readout. An EPI read-out can be done 
by acquiring all of the lines of k-space after the excitation pulse, known as “single-
shot,” or by using multiple lower flip-angle excitation pulses and acquiring a few 
lines of k-space each time, known as “multi-shot.”  
 
Figure 2.6. Gradient Echo Pulse Sequence Diagram (4). Reproduced with permission 
by the Journal of Magnetic Resonance Imaging. 
In Chapter 6, I will use a multi-shot gradient-echo acquisition scheme to 
acquire pH-weighted images to aid physicians to make individualized treatment 
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decisions for each patient. Furthermore, in Chapter 5, I will use a single-shot gradient 
echo EPI acquisition scheme to quickly acquire cerebellar blood flow-weighted 
images. 
  
2.6.4. Spin Echo Imaging Pulse Sequence 
One issue with the gradient echo imaging method is its sensitivity to magnetic 
field inhomogeneities as well as microscopic fields in the sample. One way to address 
these concerns is with a spin echo acquisition. A spin echo acquisition uses a 90° 
pulse to tilt the magnetization onto the transverse plane. When that happens, the 
magnetization begins to dephase due to T2, T2* and T2’ mechanisms. A certain time 
later, a 180° pulse is applied to invert the direction of evolution of the magnetization. 
After waiting another duration of similar length, the spin echo is formed and acquired. 
The time from applying the 90° pulse to acquiring the spin echo is known as the echo 
time (TE). In order for an echo to form at that time, the 180° pulse is applied at TE/2. 
Figure 2.7 shows the pulse sequence diagram of a spin echo sequence.  
 
Figure 2.7. Spin Echo Pulse Sequence Diagram (4). Reproduced with permission by 
the Journal of Magnetic Resonance Imaging. 
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 Equation 2.35 governs the contrast given a specific repetition time (TR) or 
echo time (TE) in a spin echo experiment.  
𝑀𝑧 = 𝑀0(1 − 𝑒−𝑇𝑅 𝑇1⁄ )𝑒−𝑇𝐸 𝑇2⁄        (Equation 2.35) 
In chapter 8, I will use the spin echo acquisition method to study 
exchangeable proton signals in bovine blood because of its high signal-to-noise and 
because it is not susceptible to local magnetic field inhomogeneities caused by 
deoxyhemoglobin. 
 
2.6.5. Gradient Spin Echo (GraSE) Imaging Pulse Sequence 
In gradient echo imaging, the static magnetic field must be highly 
homogenous, and high gradients and fast gradient switching times are also needed. 
Disadvantages of spin echo imaging includes a longer duration due to the presence of 
many 180° pulses plus high RF power deposition for the 180° pulses. One way to 
minimize the issues of gradient echo and spin echo imaging is by alternating the two 
techniques to form a gradient spin echo (or GraSE) acquisition. Figure 2.9 shows a 





Figure 2.8. Gradient Spin Echo (GraSE) Pulse Sequence (5). Reproduced with 
permission from Magnetic Resonance in Medicine. 
Using a GraSE acquisition scheme, multiple 180° pulses are used to refocus 
the magnetization to create multiple spin echoes. After each 180° pulse (each spin 
echo), multiple gradient recalled echoes are formed using the method described in 
section 2.4.2. Different speed-up factors can be achieved depending on the number of 
spin echoes and gradient echoes formed. The GraSE acquisition offers a unique way 
of acquiring true 3D images in a short amount of time. In chapter 6, we will utilize a 




 In conclusion, magnetic resonance is a versatile tool with many ways of generating 
images with different contrast mechanisms in the human body. Throughout this dissertation, 
we will apply these basic concepts of NMR to develop novel imaging methods to study acute 
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Chapter 3. Hemoglobin, Blood, and Tissue Oxygenation 
 
3.1. Hemoglobin 
Hemoglobin is a protein responsible for the transport of oxygen in many different 
organisms. In humans, unique chemical and structural features of hemoglobin allow it to bind 
oxygen in the lungs, carry it to other parts of the body, and release it. Hemoglobin is 
contained inside of erythrocytes, one of the four major components (erythrocytes, leukocytes, 
platelets, and plasma) of blood, at a 5 mM concentration. Hemoglobin contains a four heme 
groups composed of an iron molecule (Fe2+) in a porphyrin (a heterocyclic ring). The iron is 
the part of hemoglobin that binds oxygen. However, iron can only bind oxygen if it is in the 
reduced state (Fe2+). If iron is in the oxidized state (Fe3+), it is unable to bind oxygen. When 
this happens, methemoglobin reductase, an enzyme commonly found inside erythrocytes, 
will reduce the iron core to Fe2+ to allow it to bind oxygen again. When erythrocytes are 
lysed, the forward rate constant of methemoglobin reductase reduces by several fold. 
 
3.1.1. Synthesis of Hemoglobin 
The synthesis of hemoglobin requires the coordinated synthesis of heme and 
globin. Heme is synthesized in the mitochondria and begins with the condensation of 
glycine and succinyl-CoA to form 5-aminolevulinic acid (ALA), which is then 
transported to the cytosol where a set of reactions will produce coprophorynogen III. 
Then this molecule is transported back into the mitochondria to produce 
protoporphyrin IX, which the enzyme ferrochetalase then inserts iron to form the 
heme. Alpha and beta globin is synthesized from DNA on chromosomes 16 and 11, 
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respectively, in the ribosome. After the heme is formed in the mitochondria, it exits 
the mitochondria to be combined with the synthesized alpha and beta globins in the 
cytosol. 
 
3.1.2. Structure of Hemoglobin  
 When studying proteins, there are four levels of protein structure that are 
analyzed: the primary, secondary, tertiary, and quaternary structures. The primary 
structure refers to the sequence of amino acids that the protein is composed of. In the 
case of human hemoglobin, there are four subunits: 2 α subunits and 2 β subunits. In 
the alpha subunit, there are 144 amino acids, and in the beta subunit there are 146 
amino acids. The secondary structure of protein refers to the alpha helices and beta 
pleated sheets that it has. In hemoglobin, most of the alpha subunit (75%) is 
hydrogen-bonded to form several alpha helices. In the beta subunit, there are eight 
distinct alpha helices. The tertiary structure of protein is how a single subunit of a 
protein folds and is usually defined by disulfide bonds. The tertiary structure of 
hemoglobin is such that it forms a box around the heme group, which gives the Fe2+ a 
hydrophobic environment and makes it more difficult for it to be oxidized. When 
hemoglobin binds oxygen, changes in the tertiary structure occur. These changes have 
been studied with X-ray crystallography and have been detailed extensively in his 
1977 PNAS publication (1).  
 The quaternary structure of protein refers to how different subunits of a 
protein interact with each other. Hemoglobin is a tetramer because it has four subunits 
that interact with one another to form the entire protein. Hemoglobin is generally 
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thought to have two main quaternary structures or states: T or tense/taut state 
(deoxyhemoglobin) and R or relaxed state (oxyhemoglobin) (shown in figure 1.1). In 
the tense state, hemoglobin has less of an affinity for oxygen than in the relaxed state. 
Interestingly, many people have done research on this and have identified certain 
structural and chemical properties that can be used to identify hemoglobin in its tense 
or relaxed state (2-6). Many tools have been used to elucidate physical and chemical 
differences between the two quaternary structures. Using ultraviolet (UV) spectra, 
difference spectra between T state and R state contains peaks in the aromatic region at 
279, 287, 294, and 302 nm. Using UV circular dichroism, T state hemoglobin exhibits 
a band of negative ellipticity with a single maximum at 287 nm, and derivatives of the 
R structure show weak positive ellipticity in this region with slight dips at 285 nm 
and 290 nm. Using nuclear magnetic resonance, a characteristic of the R state is an 
exchangeable proton resonance 5.8 ppm downfield from water, whereas the T state 
has a characteristic exchangeable proton resonance 10.0 ppm downfield from water.  
And using SH reactivity, the rates of reaction of Cys F9 with p-mercuribenzoate are 
slowed by the R→T transition from the salt bridge formed between His HC3β and 








Figure 3.1. Structure of (A) Oxyhemoglobin and (B) Deoxyhemoglobin. (Source: 
http://en.wikipedia.org/wiki/Hemoglobin). Reproduced under the Wikimedia Commons free 
license. 
 Here we will also introduce the primary structure of bovine hemoglobin because the 
experiments mentioned in Chapter 7 will use bovine blood. In bovine blood, there are also 
four subunits: 2 α subunits and 2 β subunits. However, the bovine hemoglobin alpha subunit 
has 142 amino acids, and the beta subunit has 145 subunits. Secondary, tertiary, and 
quaternary structures of human and bovine blood are very similar. Another major difference 
between bovine blood and human blood is in the regulation of binding oxygen. In human 
blood, 2,3-bisphosphoglyceric acid (2,3-BPG) is used to regulate hemoglobin’s affinity for 
oxygen. However, in bovine blood, this is done with chloride ions. In general, bovine blood 
and human blood are closely related (7) so many scientific studies substitute bovine blood for 
human blood (8-10).  
Other than oxygen, hemoglobin is also able to bind to other molecules such as carbon 
monoxide (C=O). However, hemoglobin binds carbon monoxide with a binding constant of 
250 times that of the binding constant to oxygen (11). Therefore, when hemoglobin binds to 
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carbon monoxide, it causes grave toxicity because it inhibits the ability of hemoglobin to 
bind oxygen. Typically carbon monoxide poisoning is treated with hyperbaric oxygen 
therapy, which involves using putting a patient suffering from carbon monoxide poisoning in 
a chamber with oxygen higher than that of atmospheric pressure. It has been shown that 
delivery of oxygen at three times that of atmospheric pressure reduces the half life of carbon 
monoxide in hemoglobin to 23 minutes compared to 80 minutes at normal atmospheric 
pressure as well as provides delivery of oxygen through blood plasma. 
When carbon monoxide binds to hemoglobin, the combined protein is known as 
carbonmonoxyhemoglobin (or HbCO). Although this protein is unlikely to exist in the 
human body at high amounts, the high binding constant of carbon monoxide relative to 
oxygen makes this molecule very stable and easy to study.  
 
3.1.3. Oxygen Dissociation Curve 
 The oxygen dissociation curve (ODC) helps us understand how hemoglobin carries 
oxygen throughout our body. It relates the partial pressure of oxygen in the environment (for 
humans, the environment is the blood) to the oxygen saturation of hemoglobin and is defined 
by hemoglobin’s affinity for oxygen. The ODC has a sigmoidal shape (figure 3.2A) governed 





,𝑛 = 1 − 4           (Equation 3.1) 
Where Y is the oxygen saturation fraction, p50 is the partial pressure of oxygen at 50% 
saturation, and n is the Hill’s coefficient representing the number of oxygen molecules that 
can bind to hemoglobin. The oxygen dissociation curve can be shifted left or right depending 
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on various factors such as pH, temperature, the partial pressure of CO2, and 2,3-BPG (figure 
3.2B).  
 
Figure 3.2. Human oxygen dissociation curve. Reproduced with permission from (12). 
 The average lifetime of a red blood cell is 100-120 days. After four months of push 
(by arteries), pull (by veins), and being squeezed through small capillaries, erythrocytes 
experience eryptosis, or erythrocyte programmed cell death. During this process, 
erythrocytes undergo changes in their plasma membranes so they can be recognized by 
macrophages and phagocytosed. Hemoglobin, the major constituent of a red blood cell, is 
broken down into heme and globin. The globin can either be recycled or broken down into its 
respective amino acides, which are either recycled or metabolized. Because the iron portion 
25 
 
of the heme is valuable, it is recycled back to the bone marrow to make new heme and 
subsequently hemoglobin. The heme is then converted to bilirubin and bound to plasma 
proteins, which carries it to the liver where it is secreted as bile. 
 
3.2.  Blood, Vasculature, and Tissue Oxygenation  
Blood is responsible for delivering nutrients and oxygen to the entire body. 
Hemoglobin, previously mentioned, is responsible for binding oxygen. Figure 3.3 shows a 
cartoon diagram of the circulatory system of the human body. Oxygen is breathed in at the 
lungs where there is a high partial pressure of oxygen enabling four oxygen molecules to 
bind to hemoglobin. Blood carries this oxygen to the heart where it is then pumped to the rest 
of the body.  
 
Figure 3.3. Blood Circulation in the Human Body. Taken from the patient 
information website of Cancer Research UK: http://www.cancerresearchuk.org/cancerhelp. 
Blood leaves the heart through the aorta, a large artery, and travels through 
progressively smaller arteries until it reaches the arterioles, which feeds directly into the 
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capillary network where the walls of the blood vessels are permeable for oxygen to diffuse 
outside and oxygenate limbs and organs. Carbon dioxide and other wastes are removed from 
the tissue in these capillaries and then carried through the blood stream to be disposed of by 
other organs. The blood flow is fastest in the aorta (~50 cm/s) after leaving the heart, but 
because there is only one aorta in the human body, it is only a small portion of the entire 
vasculature.  
Blood vessels have different structural characteristics depending on the function they 
serve in transporting blood. The arteries, which carry blood away from the heart, 
accommodate flow speeds of around twice as fast as in the veins. In order to accommodate 
flow under pressures of 100 mmHg, arteries close to the heart such as the aorta and 
pulmonary arteries have thick walls containing large quantities of elastic tissue with large 
radii. Beyond the aorta, arteries have less elastic tissue and more muscular tissue. Following 
arteries, blood flows eventually flows through thinner arterioles with smooth muscle that 
regulates blood flow through vasodilatation or vasoconstriction. The flow of blood is slowest 
in capillaries where the combined surface area is largest and endothelial cell lining is thinnest 
(5-10 μm), which is optimal for nutrients to diffuse out to tissue and for waste products such 
as carbon dioxide to diffuse into the bloodstream. Capillaries then come together to form 
venules and eventually veins that carry deoxygenated blood back to heart and eventually the 
lungs to be re-oxygenated. In most people with an average heart rate of 70 times/minute and 
an average of 70 mL of blood pumped per beat (13), it will take one minute to pump blood 
around the body once (70 times/minute * 70 mL/time = 4900 mL/minute, which corresponds 





 Each person has five liters of blood in their body, and there are five million red blood 
cells in a milliliter. This corresponds to 25 trillion red blood cells in the human body. Also, 
the human brain is only 2% of the weight in a human body, yet it utilizes 20% of the 
resources in its metabolism. In this dissertation, we will focus on developing imaging 
techniques which directly or indirectly (through other parameters related to oxygenation) 
measure oxygenation in the brain. Therefore, this introduction is given to have a general 
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Chapter 4. Cerebral Ischemia: Mechanism, Diagnostic Tools, and Clinical 
Management 
 
4.1. Chapter Goal 
 The work presented throughout this dissertation relates to optimizing recently 
developed MRI methods and developing new MRI methods with the purpose of improving 
and augmenting information so physicians can make fast and accurate decisions regarding 
individualized patient therapy for cerebral ischemia. The goal of this chapter is three-fold:  
1) Introduce ischemia, defined by Merriam-Webster dictionary as the “deficient supply 
of blood to a body part that is due to obstruction of the inflow of arterial blood,” and 
describe the cascade of cellular and molecular events that unfold when ischemia 
occurs; 
2) Introduce diagnostic imaging modalities that are currently being used by physicians 
to guide treatment decisions; 
3) Introduce the options for treatment of ischemia. 
 
4.2. Pathophysiology of Ischemia 
4.2.1. Cellular and Molecular Response to Ischemia 
Ischemia happens when a thrombus or embolus partially or totally obstructs 
blood flow, and subsequently oxygen delivery, to a certain part of the body. When a 
thrombus or embolus blocks the delivery of oxygen and glucose to the brain, multiple 
events occur on a cellular and molecular level. It is important to understand the 
effects of this process to design therapies that can protect against harmful effects and 
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to design effective diagnostic tools using non-invasive imaging techniques to have a 
window into what is happening.  Another reason why this is important is because 
research has shown that ischemia is a heterogeneous disease. Patients frequently 
present with different symptoms and at different time points and require different or 
even no treatment. Molecular pathways and mechanisms that mediate neuronal injury 
include glutamate-mediated excitotoxicity, increase of intracellular calcium, acidosis, 
secondary messenger systems, inflammatory mechanisms, free radicals, cellular 
apoptosis, and nitric oxide (1).  
 
Figure 4.1. Timeline of Cellular and Molecular Events that Occur During Ischemia. 
SEP = somatically evoked potentials, EEG = electroencephalogram, hsp72 = heat 
shock protein-72. Adapted and reproduced from (2).  
During early ischemia, protein synthesis is one of the first cellular functions 
that is affected. Furthermore, when cerebral blood flow continues to decrease, heat 
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shock proteins (hsp) are activated. Heat shock proteins is one of the molecular 
hallmarks of tissue at risk of infarction because they are activated when cells are 
exposed to various types of stresses including abnormal temperatures, infection, 
inflammation, toxins, and hypoxia. In ischemia, upregulation of hsp occurs when 
neurons are exposed to hypoxic stresses and binds to proteins to maintain protein 
their structure and functionality (3).   
As blood flow continues to decrease, nitric oxide (NO), another 
neurotransmitter and neuromodulator, is activated to help and repair the brain under 
ischemic conditions.  NO has been identified to be produced in from three different 
types of protein in the brain: neuronal nitric oxide synthase (nNOS), endothelial cell-
induced NOS (eNOS), and induced NOS (iNOS). As part of the autoregulatory 
response when cerebral perfusion is reduced, eNOS serves as a neurotransmitter to 
signal blood vessels to vasodilatate to increase blood flow, and subsequently the 
delivery of oxygen, to the brain. This temporarily increases cerebral microvascular 
blood volume. Contrary to the neuroprotective effects of eNOS, nNOS and iNOS 
have both been shown to be unfavorable to tissue outcome (3). Clinical trials have 
been started to investigate how the mechanisms of NO can be translated to clinical 
therapies (4). 
Eventually, cerebral blood flow reaches a critical threshold when tissue 
acidosis occurs. When there is an insufficient supply of oxygen being delivered to the 
brain (i.e. cerebral perfusion is between 22 mL/100 g parenchyma/minute and 35 
mL/100 g parenchyma/minute) (2), neurons change from aerobic respiration to 
anaerobic respiration. When this happens, glucose is metabolized to lactate to 
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produce 2 adenosine triphosphate (ATP) (instead of pyruvate to produce 36 ATP 
under circumstances of normal cerebral perfusion), the source of molecular energy. 
During ischemia with normal serum glucose levels, pH may drop from its normal 
physiological value of 7.3-7.4 to 6.4 to 6.6. However, if cerebral perfusion is not 
quickly restored, then eventually plasma hyperglycemia occurs from the continual 
delivery of glucose, which will cause the intracellular pH to drop to 6.0. 
Finally, when ATP is completely depleted, neurons do not have the means to 
maintain ionic gradients and anoxic depolarization occurs. This is triggered by the 
nonsynaptic release of glutamate that increases concentrations of extracellular 
glutamate. Furthermore, glutamate uptake is impaired by compromised adenosine 
triphosphate (ATP) production, because when the delivery of oxygen is reduced in 
ischemia, neurons switch from aerobic respiration to anaerobic respiration. A 
combination of increased extracellular glutamate and reduced glutamate uptake leads 
to prolonged glutamate receptor activation, which causes increased cytosolic levels of 
Ca2+. Increased levels of Ca2+ can trigger lipase and protease production and other 
processes that lead to neuronal death. 
Additionally, free radicals (reactive oxygen species (ROS) and reactive 
nitrogen species (RNS)), constantly being generated in cells (mostly in the 
mitochondria), are removed by various defense mechanisms in the body. However, it 
has been shown that nicotinamide adenine dinucleotidue phosphate (NADPH) 
oxidase generates a majority of superoxide anions during ischemia and activates N-
methyl-D-aspartate (NMDA) receptors (caused by increased concentrations of 
glutamate) (5, 6). Furthermore, it has been validated that glutamate-activated NMDA 
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receptors increases ROS both in neurons and vascular cells, suggesting damage by 
vascular ROS during ischemia. Additionally, RNS significantly impacts cellular 
functions by inhibiting mitochondrial enzymes, damaging DNA, and activating Poly 
ADP ribose polymerase (PARP), which is another one of the mechanisms that leads 
to cellular apoptosis.  
 
 4.2.2. Ischemic Penumbra 
In acute stroke, when the brain has been deprived of oxygen for an extended 
of period of time, membrane ion channels fail to maintain an ionic gradient, apoptotic 
mechanisms initiate, water rushes into the cell, and cytotoxic edema occurs in a core 
region. However, it was noticed that in areas surrounding this “core” key neurological 
functions (e.g. protein synthesis, aerobic metabolism) are suppressed to conserve 
energy. In 1977, the concept known as the ischemic penumbra was proposed by 
Astrup as a region of tissue that was functionally silent but anatomically intact (7). 
However, this region of “misery perfusion” was not visualized for the first until 1981 
by Baron et al using positron emission tomography (PET) imaging (8). Figure 4.2 
augments figure 4.1 to approximate the flow values where the ischemic penumbra is 




Figure 4.2. How Cellular and Molecular Events Following Ischemia Relate to the 
Ischemic Penumbra. Reproduced with permission from (2). 
Imaging the ischemic penumbra has been a primary focus of acute stroke 
imaging research. In the next few sections, we will outline how imaging the ischemic 
penumbra has evolved over the past 30 years. Following the imaging techniques, we 
will introduce current treatments for ischemic stroke and explain what imaging 
techniques need to be developed and validated for more patients to be exposed to 
these treatments.  
 
4.3. Imaging Diagnosis of Ischemic Stroke 
 The utility of imaging as applied to ischemic stroke arises from the necessity to 
determine what course of therapy is most suitable for each particular patient. Because 
ischemic strokes are of a heterogeneous nature, stroke therapy evolves quickly tailoring 
unique treatments to each unique case. 
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 Here, we introduce the different imaging modalities that have been used to image the 
ischemic penumbra and guide therapeutic options for patients. We begin with positron 
emission tomography, the first imaging modality applied to imaging ischemic stroke, and 
then we move to the more popular computed tomography, where a stroke exam can be 
finished in 10 minutes. Finally, we introduce magnetic resonance imaging and the different 
contrasts it offers and how they help construct a comprehensive stroke examination. 
 
 4.3.1. Positron Emission Tomography (PET) 
Positron Emission Tomography (PET), developed in 1951 and applied to 
humans in 1953, was the first imaging modality applied to image acute stroke to view 
the ischemic penumbra. It relies on the injection of a radiotracer on a biologically 
active molecule to measure different metabolic functions of the body (depending on 
which radiotracer is being injected). H2O15, more commonly known as O-15 water, is 
a commonly used radiotracer for measuring cerebral blood flow (CBF) with PET. 
Figure 4.3 shows PET images from a patient who presented with right hemiparesis (8). 
Here, CBF was measured using a 15O-water intravenous bolus method with 20 mCi, 
then the patient inhaled 50 mCi 15O2 gas in a single breath. Arterial blood sampling 
from a radial artery catheter yielded regional values for CBF (Figure 4.3A), cerebral 
metabolic rate of oxygen (CMRO2) (Figure 4.3B), and oxygen extraction fraction 
(OEF) (Figure 4.3C).    
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(A)  (B)  (C)  
Figure 4.3. PET Imaging of Ischemic Penumbra. (A) Cerebral Blood Flow  
(B) Cerebral Metabolic Rate of Oxygen (C) Oxygen Extraction Fraction. Reproduced 
with permission from (9). 
 This patient has a region of the brain that has no delivery of oxygen of the 
brain indicated by the hypointensity in the cerebral blood flow image of figure 4.4A. 
A subset of the hypointensity in the cerebral blood flow image is shown to not be 
metabolizing oxygen in the CMRO2 image of figure 4.4B. And in figure 4.4C, we see 
that the oxygen extraction fraction is significantly increased (red area) in the 
difference between the hypointensities of figure 4.4A and 4.4B and increased in other 
areas characterized in green. This would point out that the region that is not 
metabolizing oxygen has most likely irreversibly progressed to infarction (the core of 
the infarct). If therapy is provided to restore blood flow, then the regions in figure 
4.3C denoted by red and green could possibly be salvaged (ischemic penumbra).  
However, PET has a few disadvantages. First, it requires the injection of a 
radioactive tracer into the human body. And second, the radiotracer is not widely 






4.3.2. Computed Tomography (CT) 
Computed tomography is currently used in many emergency departments to 
quickly evaluate whether or not a patient is suitable for thrombolytic therapy. A 
typical multi-modal computed tomographic (CT) scan for an acute stroke patient 
takes 10 minutes and is comprised of three scans: 1) Noncontrast Head CT; 2) CT 
Angiography; 3) CT Perfusion. Table 4.1 summarizes each CT modality and how it is 





Table 4.1. Components of a Multimodal CT Acute Stroke Examination. (9) 
Imaging Modality Clinical Use 
Noncontrast Head CT 
- Excludes or diagnoses intracranial hemorrhage. 
- May identify certain stroke mimics (e.g. tumor,  
   infection), arterial occlusion, or early signs of  
   infarction. 
- Diagnoses subarachnoid hemorrhage (SAH). 
- Detects large ischemic strokes and infarcts. 
CT Angiography 
- Evaluates the intracranial and extracranial arterial  
    circulation for occlusion or stenosis. 
- Evaluates for some secondary causes of intracerebral  
     hemorrhage and vascular abnormalities in SAH (e.g.   
     aneurysms, arteriovenous malformations). 
CT Perfusion 
- Quantifies cerebral blood volume, cerebral blood flow,  
    and mean transit time for blood flow through brain  
    tissue. 
A noncontrast head CT (NCCT) is acquired on a CT scanner, which creates 
images using an x-ray tube mounted on one side of a rotating frame with an arc-
detector on the other side. One slice is acquired when the rotating frame creates a fan 
beam of x-ray around the patient and detects it. This process can be repeated multiple 
times to acquire a volume of slices over the whole brain. CT Angiography (CTA) 
images are acquired by injecting an iodine-based contrast agent intravenously 
(typically through the arm) into the patient. This non-invasive procedure yields 
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similar information to an angiogram, which requires a catheter to be inserted into the 
patient from the femoral artery to deliver contrast agent at the site of interest. CTAs 
reduce the risk of infection and perforation of an artery during an angiogram. CT 
Perfusion (CTP) images are derived by acquiring CT images also while an iodine-
based contrast agent is injected intravenously into the patient. Deconvolution and 
other mathematical models (such as the central volume principle) can be employed to 
calculate maps of cerebral blood flow (CBF), cerebral blood volume (CBV), and 
mean transit time (MTT) based on the central volume principle. Cerebral blood 
volume is defined as the microvascular blood volume (introduced in section 4.2.1), 
the amount of blood that is in the arterioles, capillaries, and venules. As previously 
mentioned under conditions of reduced cerebral perfusion, cerebral autoregulatory 
mechanisms will release NO leading to vasodilatation of cerebral microvessels and 
increased cerebral blood volume. Additionally, mean transit time can be calculated as 
the ratio of cerebral blood volume to cerebral blood flow. Thus, MTT is a quantity 
with units of time and gives information about the average time it takes for blood to 
traverse the cerebral microvasculature. In normally perfused tissue, average mean 
transit times measured by CTP are around four seconds, but in ischemic regions, this 
can increase up to twelve seconds (11). However, the accuracy of these mathematical 
models and the reproducibility of CTP is currently still being debated (12).   
Figure 4.4 shows state-of-the-art multimodal CT images of an acute stroke 
patient (13). Figure 4.4A, the noncontrast head CT image for this patient is 
unremarkable and shows no evidence of infarction or tissue at risk of infarction. 
Figure 4.4B-D show results of the perfusion CT scan, which shows reduced cerebral 
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blood flow (CBF) (Figure 4.4B, white arrows), asymmetric cerebral blood volume 
(CBV) (Figure 4.4C, white arrows), and mean transit time (MTT) (Figure 4.4D) 










Figure 4.4. State-of-the-art Multimodal CT Images of an Acute Stroke Patient.  
(A) Noncontrast Head CT (B) Cerebral Blood Flow (CBF) (C) Cerebral Blood 
Volume (CBV) (D) Mean Transit Time (MTT). Reproduced with permission from 
(12). 
 
 4.3.3. Magnetic Resonance Imaging (MRI) 
Although it has not yet reached a mainstream diagnostic tool for ischemic 
stroke, magnetic resonance imaging (MRI) has a lot of information to offer to doctors 
who are deciding what course of treatment to give a patient and how that treatment is 
progressing. Two major benefits MRI offers to the acute stroke field are: 1) non-
ionizing radiation and 2) a myriad of contrast mechanisms. Unlike CT and PET, MRI 
scans do not leave patients with traces of harmful ionizing radiation. Additionally, 
MRI offers a plethora of different contrast mechanisms by varying how 
radiofrequency (rf) pulses are played out (or pulse sequence). A few examples of 
MRI contrasts that are currently used in the diagnosis of acute ischemia include 
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FLuid Attenuated Inversion Recovery (FLAIR), GRadient Echo (GRE), Magnetic 
Resonance Angiography (MRA), Diffusion Weighted Imaging (DWI), and Perfusion 
Weighted Imaging (PWI). Table 4.2 outlines a few of the modalities that are 
commonly used to image acute stroke patients and the clinical relevance of those 
scans.  
Table 4.2. Multimodal MRI Acute Stroke Protocol Used at Johns Hopkins Hospital. 
Imaging Modality Clinical Use 
Diffusion-Weighted 
Imaging (DWI) 




- Assess for cerebral microbleeds. 
- Rule out intracerebral hemorrhage. 
Perfusion-Weighted 
Imaging (PWI) 









- Assess for extent of infarcted tissue, small vessel disease, 
and prior territorial infarction. 
- Rule out subarachnoid hemorrhage. 
Diffusion-weighted imaging (DWI) uses the addition of field gradients to an 
MRI acquisition to sensitize it to water diffusion (14). This is mostly done using spin 
echo acquisition, but other approaches are also possible. In acute stroke, DWI is 
particularly useful to visualize regions of the brain in which there is insufficient 
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energy (ATP) to maintain cellular ion channel patency and cytotoxic edema has 
occurred. Because of DWI’s sensitivity to imaging water diffusion, regions where 
cytotoxic edema have occurred have more restricted water diffusion on average, and 
these regions appear hyperintense in diffusion-weighted images where the strength of 
the gradient is high. An example of this can be seen in figure 4.5A. Recent research 
has shown that hyperintense regions on diffusion-weighted images in acute stroke 
patients progress to infarction. This has led to the use of DWI to visualize the “core” 
of the stroke. 
Dynamic susceptibility contrast perfusion-weighted imaging (DSC-PWI) 
tracks the injection of a gadolinium-based contrast agent that changes the relaxation 
properties of the tissue it passes through. As the contrast agent passes through the 
tissue of interest (in stroke, it is the brain), images are rapidly acquired (15, 16). 
Through equations that relate signal intensity to relaxation (T2*) and using the central 
volume principle, the data then can be reconstructed to yield maps of cerebral blood 
volume (CBV), cerebral blood flow (CBF), mean transit time (MTT), and time-to-
peak (TTP). These images can then be used to map regions of reduced perfusion. The 
combination of hyperintensities in diffusion-weighted and perfusion-weighted images 
(known as the diffusion-perfusion mismatch (DPMM)) can yield information on the 
ischemic penumbra (figure 4.5A and figure 4.5B). Unfortunately, studies have 
analyzed the effectiveness of using the DPMM to evaluate treatment options for 













Figure 4.5. Multimodal MRI of an Acute Stroke Patient illustrating ischemic 
penumbra with diffusion-perfusion mismatch. (A) Diffusion-weighted Image shows a 
small lesion (hyperintensity) in the deep middle cerebral artery vascular territory. (B) 
Hyperintensity in Time-to-Peak weighted Image (calculated from Perfusion-
Weighted Imaging) and (C) Magnetic Resonance Angiography show complete 
occlusion of the left middle cerebral artery territory. (D) Fluid-Attenuated Inversion 
Recovery showing final infarct. Reproduced with permission from (18).  
In addition to not being effective at estimating tissue at risk of infarction, it 
has recently been observed that a small group patients with compromised kidney 
function who had received one or more exposures to gadolinium-based contrast 
agents (GBCA) from DSC-PWI develop nephrogenic systemic fibrosis (NSF), a 
fibrosing disease that mainly affects the skin and subcutaneous tissues but can also 
affect other organs too. Currently, there is no effective treatment for this disease, 
which has been fatal to some patients. Thus a set of recommendations have been 
developed that advises doctors not to administer gadolinium-based contrast agents to 
patients with a glomerular filtration rate (GFR) of less than 30 ml/min/1.73m2 (19). 
Therefore, it is important to develop non-invasive techniques with higher sensitivity 
to detect tissue at risk of infarction. This will be done in Chapter 5, where we will use 
a non-invasive method to measure cerebral blood volume and apply this method to 
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acute ischemic stroke patients to study whether relative increases in cerebral blood 
volume is a good indicator of tissue that may progress to infarction. We will also 
introduce another non-invasive method in Chapter 6 where we will use pH-weighted 
imaging to study pH changes in acute ischemia. 
 
4.4. Clinical Management of Cerebral Ischemia 
 Before imaging technologies were available, acute stroke was deemed an untreatable 
disease where physicians could only make patients as comfortable as possible while they 
waited for patients to stabilize. Now, doctors, equipped with multiple imaging modalities and 
with blood thinners and clot busting agents at their side, can manage the disease as it 
progresses. Currently, the three most commonly used therapies include intravenous tissue 
plasminogen activator (IV-tPA), intra-arterial tPA (IA-tPA), and mechanical thrombectomy 
where devices are used to mechanically retrieve the clot.  
 
 4.4.1. Intravenous Tissue Plasminogen Activator (IV-tPA) 
Tissue plasminogen activator (or tPA) is a protein involved in breaking down 
blood clots. It catalyzes the conversion of plasminogen to plasmin, the main enzyme 
responsible for the breakdown of clots to fibrin degradation products (FDPs).  
Currently, tPA is the only approved drug by the United States Food and Drug 
Administration (USFDA) for thrombolysis of the blood clot, and it is only approved 
for usage within a three hour window. This means that patients must present within 
three hours of onset of ischemic stroke symptoms and have the contraindications of 
tPA ruled out in order to be eligible to receive tPA. In reality, less than 5% of patients 
that present with acute ischemic stroke receive tPA although many more patients 
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could benefit from it. One disadvantage of tPA is that it causes hemorrhage in 5% of 
the patients that it is used in. Therefore, it is extremely important to have diagnostic 
tools that accurately identify patients who can benefit from tPA. 
 
 4.4.2. Intra-arterial tPA (IA-tPA) 
Intra-arterial administration of thrombolytic agents offer a higher 
concentration of drug delivery to the therapeutic site and open the treatment window 
from three (treatment by IV-tPA) to six hours. IA-tPA is also used for patients who 
have recently had surgery or are on blood thinners. The procedure for IA-tPA begins 
by inserting a catheter in the groin area and threads it up to the brain. Then tPA is 
administered locally to break up the clot, and pieces of the clot are then physically 
removed from the brain using a device integrated with the catheter. Because IA-tPA 
requires the insertion of a catheter, IA-tPA is more invasive than IV-tPA. 
 
 4.4.3. Mechanical Thrombectomy 
  Beyond the tPA therapeutic windows (> 6 hours) for thrombolytic therapy, 
many stroke physicians have turned to mechanical thrombectomy. Currently, there 
are two FDA-approved devices in the United States. One of them is known as the 
Merci retriever device that is composed of a wire in a spring device that is positioned 
distal to the thrombus, then it is mechanically used to extract the thrombus from the 
vessel. The other device is called the penumbra system, which is used to break up the 
clot and aspirate the pieces through a reperfusion catheter connected to a vacuum 




4.5. Clinical Trials 
A clinical trial, Echoplanar Imaging Thrombolysis Evaluation Trial (EPITHET), has 
been performed to evaluate the benefit of giving intravenous tissue plasminogen activator 
beyond the currently FDA-approved three hour window (19). Diffusion and Perfusion 
Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) (20) and Diffusion and 
Perfusion Imaging Evaluation for Understanding Stroke Evolution-2 (DEFUSE-2) (21), are 
two clinical trials that have evaluated whether patients with diffusion-perfusion mismatch 
selectively treated with iv-TPA would have a favorable clinical outcome.  
EPITHET was a double-blind clinical trial that studied whether iv-TPA was effective 
for patients with a DPMM beyond three hours of stroke onset. To test this hypothesis, a one 
hundred and one patients were enrolled and stratified into two groups: fifty-two patients 
received the thrombolytic agent, and forty-nine patients received a placebo three to six hours 
after onset of ischemic stroke. Patients were scanned on a 1.5T MRI machine with standard 
DWI, PWI, and MRA sequences. Imaging mismatch was defined as a perfusion to diffusion 
lesion ratio of 1.2 and at least a 10 mL PWI and DWI lesion volume. Reperfusion was 
defined as a greater than 90% attenuation of the PWI lesion between baseline and day three. 
A good neurological outcome was defined as a National Institutes of Health Stroke Scale of 0 
or 1 at day 90 or improvement of eight or more points from baseline. A good functional 
outcome was defined as a modified Rankin Score at day 90 of zero to two. The primary 
hypothesis was patients with imaging mismatch who received iv-TPA would have larger 
attenuation of infarct growth. The primary method of analysis was the ratio of the geometric 
mean (defined as the exponential of mean log relative growth). Secondary methods of 
analyses included relative growth, absolute growth, and difference in cube root lesion 
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volumes. A secondary hypothesis was that patients with imaging mismatch who received iv-
TPA were more likely to reperfuse and achieve good neurological and functional outcome. 
Data were analyzed before revealing treatment allocation. When analyzing the data using the 
primary method of analysis, the authors negatively concluded (primary hypothesis) lower 
infarct growth in mismatch patients with iv-TPA. However, secondary methods of analyses 
support the primary hypothesis that iv-TPA can reduce infarct growth beyond three hours. 
With regards to the second hypothesis, the authors concluded that occurrence of reperfusion 
was significantly higher in the patients with mismatch who received iv-TPA than in those 
who received the placebo. However, the occurrence of good neurological and functional 
outcome did not differ between treatment groups. In conclusion, intravenous tissue 
plasminogen activator increased reperfusion in patients who presented three to six hours after 
symptom onset and was strongly associated with a reduction of infarct growth and good 
neurological and functional outcome.  
The authors of the DEFUSE clinical trial hypothesized and confirmed that patients 
with a DPMM profile who received iv-TPA had a more favorable clinical outcome (20). In 
this trial, seventy-five patients were enrolled between April 2001 and April 2005. Patients 
were divided into four different categories based on the presentation of their DPMM: 1) A 
“Mismatch” profile was defined by a presentation of the PWI lesion that was 120% or greater 
and 10 mL or more of the DWI lesion. A subset of this group who did not have a PWI lesion 
of 100 mL or more with a Tmax delay of eight seconds or longer was known as the “Target 
Mismatch” profile; 2) Patients with a DPMM who did have a PWI lesion of 100 mL or more 
with a Tmax of eight seconds or longer were categorized as the “Malignant” profile; 3) A 
“Small Lesion” profile was established by DWI and PWI lesions of less than 10 mL; and 4) 
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A “No Mismatch” profile was defined by a PWI lesion volume of less than 120% of the DWI 
lesion volume. Of the fifty-four percent of patients with a “Mismatch” profile, fifty-six 
percent had a favorable clinical response with early reperfusion (defined as a 30% or greater 
and 10 mL or more reduction in the PWI lesion volume on the three to six hour follow-up 
scan) versus nineteen percent who did not have a favorable clinical response. It was also 
observed that patients with a “Small Lesion” profile typically had favorable clinical 
outcomes. Of the patients with a “No Mismatch” profile, none of the four patients with early 
reperfusion had a favorable clinical response compared to five out of seven patients who did 
not have early reperfusion. Furthermore, early reperfusion in “Target Mismatch” patients 
were associated with a favorable clinical outcome in sixty-seven percent of patients 
compared to nineteen percent who did not have early reperfusion. The three patients with a 
“Malignant” profile that received early reperfusion all had symptomatic intracranial 
hemorrhages and died. The authors concluded that acute MRI scans are able to identify 
patients that could potentially benefit from early reperfusion therapies from patients who are 
unlikely to benefit or may even be harmed. 
In DEFUSE-2, investigators studied whether MRI can aid in identifying patients who 
could potentially benefit from endovascular stroke treatment (21). A hundred and four 
patients were studied from eight centers in the United States and one in Austria between July 
2008 and September 2011. MRI scans were taken before treatment, within twelve hours of 
revascularization, and five days after treatment. The target DPMM was defined as a ratio of 
1.8 or more between the volume of the perfusion lesion (defined as Tmax > 6 s) and the 
volume of the diffusion lesion (defined as an apparent diffusion coefficient of less than 
600x10-6 mm2/s) and. A patient was considered to have early reperfusion if they had more 
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than 50% reduction in the volume of the perfusion-weighted MRI lesion between baseline 
and follow-up. A favorable clinical response was defined as an improvement in the NIHSS 
score of eight points or more between the baseline and day thirty score. Similar to the 
DEFUSE trial, the authors concluded that pre-treatment (or baseline) MRI data with 
automated imaging analysis software can be used to stratify ischemic stroke patients into two 
groups: 1) patients with the target DPMM who received reperfusion had significantly better 
clinical outcomes than those who did not receive reperfusion; and 2) patients with no target 
mismatch who show no correlation between those who did or did not receive reperfusion.  
 
4.6. Conclusion 
 In conclusion, because of the current availability of several treatment options for 
acute stroke, one has the need for imaging methods that can accurately determine the optimal 
course of treatment on a per patient basis. Issues that complicate this include the 
heterogeneity of how acute ischemic stroke presents, the time limitation of treatment options 
available, and the invasiveness of treatment options. Newer imaging techniques are being 
developed to yield more specific information so physicians can make informed decisions on 
how patients can be treated. In this dissertation, we will investigate how we can apply 
advanced imaging techniques to non-invasively image the ischemic penumbra via cerebral 
blood volume information (Chapter 6), tissue acidosis information (Chapter 7) and how we 
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Chapter 5: Assessing Cerebral Blood Volume Changes in Acute Ischemic 
Stroke Patients Using Magnetization Transfer-Enhanced Vascular Space 
Occupancy (MT-VASO)  
 
5.1. Abstract 
 It is widely known that thrombolytic therapy (intravenous tissue plasminogen 
activator, tPA) if given quickly after the occurrence of an ischemic stroke can significantly 
improve clinical outcome. To evaluate whether a candidate should receive thrombolytic 
therapy, the diffusion-perfusion mismatch based on magnetic resonance imaging can be used. 
However, the region of reduced perfusion that is at risk of infarction is frequently 
overestimated with current gadolinium-based perfusion weighted imaging. Recent literature 
has shown that increased cerebral blood volume (CBV) may be a marker for salvageable 
tissue in acute ischemia patients. The hypothesis is that, following an occlusion, the body’s 
autoregulatory mechanism will allow blood vessels in the affected region to vasodilatate to 
accommodate for more blood to be transported to the area. However, over time these blood 
vessels will exhaust their capacity and collapse.  
 Vascular Space Occupancy (VASO) MRI uses blood nulling to asses changes in CBV. 
In this study, we explore the feasibility of using magnetization transfer-enhanced VASO 
MRI as a diagnostic tool for evaluating the ischemic penumbra, or salvageable region, in 
acute stroke patients. Data for this technique is presented for three patients. Initial analysis 
shows that this technique is able to capture a larger region of tissue that eventually progresses 
to infarction, but is not as well localized as gadolinium-based mean transit time and time to 
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peak maps. Other drawbacks of the technique include that analysis is currently limited to 
white matter and can be confounded by changes in longitudinal relaxation times.  
 
5.2. Introduction 
Stroke, the third leading cause of death and leading cause of disability, affects 
approximately fifteen million people each year in the world (1). Acute ischemic stroke, 
caused by the occlusion of cerebral blood vessels by an arterial embolus or thrombus, 
accounts for approximately 85% of cases (2). A number of studies have shown that 
thrombolytic treatment with intravenous tPA to restore blood flow can be useful for reducing 
tissue infarction when given within the first 3-6 hours post-onset (3). However, the benefit of 
tPA must be weighed against the risk of intracranial hemorrhage (4-6), which occurs in 
approximately 6% (7) of cases in which patients are treated with tPA and frequently leads to 
irreversible damage. The ability to quickly and accurately assess whether patients have 
salvageable ischemic tissue is critical to improving functional outcome and minimizing long-
term disability. 
tPA has a number of contraindications for its usage (8). The most important one is 
evidence of hemorrhage, which can be assessed by CT or MRI. Of these, CT is faster, but 
MRI is more versatile in that it offers other contrasts. Diffusion-weighted imaging (DWI) and 
dynamic susceptibility contrast-based perfusion-weighted imaging (PWI) are MRI-based 
scans that are frequently used to evaluate whether a patient would be a good candidate for 
tPA. Specifically, DWI is able to portray regions where disruption of the cellular membrane 
potential has occurred. This corresponds to tissue that is likely to progress to infarction, even 
though exceptions are known to occur. DSC PWI employs the use of an exogenous 
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gadolinium-based tracer; following the tracer as a function of time allows for qualitative 
assessment of mean transit time (MTT), time to peak (TTP), cerebral blood flow (CBF), and 
cerebral blood volume (CBV) (9, 10). All of the parametric maps derived from the PWI scan 
can be used to determine regions of the brain that are functionally intact but potentially at 
risk of infarction if the ischemia is not reversed. These regions are indicators of the suitability 
for thrombolytic treatment with tPA. Thus, the DWI/PWI mismatch, or “perfusion penumbra,” 
can be used in principle to assess the extent of tissue that is ischemic but has not yet 
proceeded to infarction. However, the actual ischemic penumbra, or region at true risk of 
infarction, is not always easy to identify from the DWI/PWI mismatch. There have been 
numerous reports that the penumbra defined by PWI frequently overestimates the actual 
region at risk (11). This is because reductions in perfusion imaged with PWI span over two 
regions: (1) an oligemic region that contains benign reductions in blood flow that will 
eventually revert to normal perfusion, and (2) a region that, if left untreated, will progress to 
infarction.  Recent evidence has shown that microvascular CBV (12-15) changes in the early 
stages of ischemia. During ischemia, microvascular CBV adjusts as a consequence of blood 
pH reduction (16, 17), which lead to relaxation of smooth muscle cells and vasodilatation 
(increased CBV).  
Vascular Space Occupany (VASO) MRI is an inversion recovery-based sequence 
where the inversion time (TI) is equal to the nulling time of blood, and at that time while 
blood magnetization is zero, the magnetization of parenchyma is slightly positive (18). 
Figure 5.1 shows an image of the VASO pulse sequence and a graph that shows how much 




Figure 5.1. VASO MRI Pulse Sequence. Reproduced with permission from (19). 
VASO has been used to assess CBV changes in fMRI, Alzheimer’s disease, carotid 
artery stenosis patients, and leukoaraiosis (18, 20-22). One major disadvantage of VASO is 
its low signal-to-noise ratio (SNR). Magnetization Transfer-Enhanced VASO (MT-VASO) 
uses a magnetization transfer pulse at an offset far away from the center frequency of water 
to reduce the tissue magnetization before the inversion pulse to increase SNR by 40-50% 
(23). In this study, we used MT-VASO to acquire images weighted by CBV. 
Our hypothesis is that patients with regions of increased CBV have not yet exhausted 
autoregulatory mechanisms and could benefit from thrombolysis. Here we explore the 
feasibility of using Magnetization Transfer (MT-VASO) to visualize tissue at risk of 
infarction in acute cerebral ischemia patients in a clinically feasible time frame.  MT-VASO 
may provide a two-prong benefit to current methods for looking at the ischemic penumbra: (1) 
MT-VASO is a non-invasive MRI technique, while numerous studies have linked 
occurrences of nephrogenic systemic fibrosis (NSF) to use of gadolinium-based contrast 





5.3. Materials and Methods 
5.3.1. Simulations 
Simulations were performed using the VASO model described in Donahue et 
al (19) to determine how the VASO signal intensity would change for various 
increases in microvascular CBV. Modifications for the MT pulse from Hua et al (23) 
were added to account for the effects of the magnetization transfer (MT) pulse. 
Parameters for the simulation are listed in Table 5.1. The total MRI signal (𝑆𝑡𝑜𝑡𝑎𝑙) in 
Equation 5.1 can be described using a three-compartment (gray matter parenchyma 
(𝑆𝐺𝑀 ), white matter parenchyma (𝑆𝑊𝑀 ), CSF (𝑆𝐶𝑆𝐹 )) slow-exchange biophysical 
model.  
𝑆𝑡𝑜𝑡𝑎𝑙 = (1 − 𝑋𝑊𝑀 − 𝑋𝐶𝑆𝐹) ∙ 𝑆𝐺𝑀 + 𝑋𝑊𝑀 ∙ 𝑆𝑊𝑀 + 𝑋𝐶𝑆𝐹 ∙ 𝑆𝐶𝑆𝐹 (Equation 5.1) 
  𝑆𝑖~(𝐶𝑖 − 𝐶𝐵𝑉𝑖 ∙ 𝐶𝑏) ∙ 𝑀𝑖𝑁𝑆(𝑇𝑅,𝑇𝐼) ∙ 𝑒
− 𝑇𝐸𝑇2,𝑖 + 𝐶𝐵𝑉𝑖 ∙ 𝐶𝑏 ∙ 𝑀𝑏𝑁𝑆(𝑇𝑅,𝑇𝐼) ∙ 𝑒
− 𝑇𝑅𝑇2,𝑏,
 𝑖 = 𝐺𝑀,𝑊𝑀         (Equation 5.2) 
where b is blood, MNS(TR,TI) is the longitudinal magnetization after non-selective 
(NS) inversion, T2 is the transverse relaxation time, and CBV is the CBV fraction in 
units of ml blood/ml parenchyma (VASO units). The units for MR signal are 
magnetization/ml tissue for a given voxel, based on the units of M (magnetization/ml 
water), X (dimensionless), and the water density C (ml water/ml tissue). 
The Bloch equations can be simulated to account for the effect of reducing the 
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𝑖 − 2𝜋 ∙ ∆ ∙ 𝑀𝑥𝑖 + 𝜔1 ∙ 𝑀𝑧𝑖      (Equation 5.5) 
Where 𝑀𝑖 is the proton magnetization of the bulk water (w) or macromolecule (m) 
pools, respectively, that is exchange with the other pool (j), 𝑇1𝑖 is the T1 in pool i, 𝑇2𝑖 is 
the T2 in pool i, Rij is the exchange rate constant, and Δ is the chemical shift offset for 
the particular pool.  
However, this has been derived elsewhere so we will not review it detail here (23). 
After accounting for the effect of the MT pulse (𝑀𝑇𝑝𝑢𝑙𝑠𝑒,𝑗), we get to equation 5.6.   
𝑀𝑗𝑁𝑆(𝑇𝑅,𝑇𝐼) = 𝑀0 �1 − 2 ∗ 𝑀𝑇𝑝𝑢𝑙𝑠𝑒,𝑗 ∗ 𝑒
− 𝑇𝐼𝑇1,𝑗 + 𝑒
− 𝑇𝑅𝑇1,𝑗�   
 𝑗 = 𝐶𝑆𝐹,𝐺𝑀,𝑊𝑀, 𝑏       (Equation 5.6) 
Notice that MTpulse is listed for CSF, GM, WM, and blood. However, previous 
work has shown that the MT pulse does not affect blood (23). The contributions to 
MR water signal from CSF and the parenchymal compartments (extravascular tissue 
signal + microvascular blood signal) are given by Equation 5.1. Under steady-state 
conditions, the effect of the non-selective (NS) inversion is described by Equation 5.2. 
Simulations were performed based on information from Derdeyn et al that 
microvascular CBV changes up to 150% can occur under the autoregulatory range 
(25). The inversion time (TI) for blood was calculated to be 1081 ms given a 
repetition time (TR) of 6000 ms using Equation 5.2. All simulations were written in 




















5.3.2. Derivation of VASO Model to Estimate Ipsilateral CBV in Acute Stroke 
We begin with the VASO model equations (Equations 5.2 and 5.3). 
𝑆𝑖~(𝐶𝑖 − 𝐶𝐵𝑉𝑖 ∙ 𝐶𝑏) ∙ 𝑀𝑖𝑁𝑆(𝑇𝑅,𝑇𝐼) ∙ 𝑒
− 𝑇𝐸𝑇2,𝑖 + 𝐶𝐵𝑉𝑖 ∙ 𝐶𝑏 ∙ 𝑀𝑏𝑁𝑆(𝑇𝑅,𝑇𝐼) ∙ 𝑒
− 𝑇𝐸𝑇2,𝑏,   
𝑖 = 𝐺𝑀,𝑊𝑀           
𝑀𝑗 = 𝑀0�1 − 2 ∙ 𝑀𝑇𝑝𝑢𝑙𝑠𝑒,𝑗 ∙ 𝑒−𝑇𝐼/𝑇1,𝑗 + 𝑒−𝑇𝑅/𝑇1,𝑗�, 𝑗 = 𝐺𝑀,𝑊𝑀,𝐶𝑆𝐹, 𝑏𝑙𝑜𝑜𝑑  
  
Simulation Parameters Value Units Source 
Echo time 12.25 ms Sequence parameter 
T1 Gray matter 1209 ms (26) 
  White matter 758 ms (26) 
  Blood 1627 ms (26) 
  Cerebrospinal Fluid 4300 ms (26) 
T2 Gray matter 70.8 ms (19) 
  White matter 81 ms (26) 
  Arterial Blood 123 ms (19) 
 
Venular Blood 34 ms (19) 
  Cerebrospinal Fluid 1442 ms (19) 
C Gray matter 0.89 
mL H20/mL 
compartment (27) 
  White matter 0.73 
mL H20/mL 
compartment (28) 
  Blood 0.87 
mL H20/mL 
compartment (28) 
  Cerebrospinal Fluid 1 
mL H20/mL 
compartment (28) 
CBV Gray matter 0.053 
mL/100 g 
parenchyma (19) 
  White matter 0.02 
mL/100 g 
parenchyma (19) 
MT pulse Duration  240 ms Sequence Parameter 
 
Strength (B1) 2 µT Sequence Parameter 
 
Offset -40 ppm Sequence Parameter 
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In a VASO experiment, data is acquired when blood is nulled so we can set 
this equation to 0. 
𝑪𝑩𝑽𝒊 ∙ 𝑪𝒃 ∙ 𝑴𝒃𝑵𝑺(𝑻𝑹,𝑻𝑰) ∙ 𝒆−𝑻𝑬/𝑻𝟐,𝒃 = 𝟎     (Equation 5.7) 
𝑆𝑊𝑀~(𝐶𝑊𝑀 − 𝐶𝐵𝑉𝑊𝑀 ∙ 𝐶𝑏) ∙ 𝑀0 ∙ �1 − 2 ∙ 𝑒
− 𝑇𝐼𝑇1,𝑊𝑀 + 𝑒
− 𝑇𝑅𝑇1,𝑊𝑀� ∙ 𝑒
− 𝑇𝐸𝑇2,𝑊𝑀 + 𝟎 
 (Eq. 5.8) 
This equation is problematic because we do not have a way of quantifying M0 
from our data. If we assume that the signal on the ipsilateral side of the brain will be 
different from the signal on the contralateral side of the brain due to hypothesized 
increased microvascular cerebral blood volume, then we can further write down these 
next two equations. 
𝑆𝑊𝑀,𝑖𝑝𝑠𝑖 = �𝐶𝑊𝑀,𝑖𝑝𝑠𝑖 − 𝐶𝐵𝑉𝑊𝑀,𝑖𝑝𝑠𝑖 ∙ 𝐶𝑏� ∙ 𝑀0 ∙  
(1 − 2 ∙ 𝑒
− 𝑇𝐼𝑇1,𝑊𝑀,𝑖𝑝𝑠𝑖 + 𝑒
− 𝑇𝑅𝑇1,𝑊𝑀,𝑖𝑝𝑠𝑖) ∙ 𝑒
− 𝑇𝐸𝑇2,𝑊𝑀,𝑖𝑝𝑠𝑖 (Eq. 5.9) 
𝑆𝑊𝑀,𝑐𝑜𝑛𝑡𝑟𝑎 = �𝐶𝑊𝑀,𝑐𝑜𝑛𝑡𝑟𝑎 − 𝐶𝐵𝑉𝑊𝑀,𝑐𝑜𝑛𝑡𝑟𝑎 ∙ 𝐶𝑏� ∙ 𝑀0 ∙  
(1 − 2 ∙ 𝑒
− 𝑇𝐼𝑇1,𝑊𝑀,𝑐𝑜𝑛𝑡𝑟𝑎 + 𝑒
− 𝑇𝑅𝑇1,𝑊𝑀,𝑐𝑜𝑛𝑡𝑟𝑎) ∙ 𝑒
− 𝑇𝐸𝑇2,𝑊𝑀,𝑐𝑜𝑛𝑡𝑟𝑎 (Eq. 5.10) 
If we assume that the T1 and T2 of the white matter on both sides of the brain 
is the same (i.e. tissue relaxation has not begun to change in the ipsilateral side so 
𝑇1,𝑊𝑀,𝑐𝑜𝑛𝑡𝑟𝑎 = 𝑇1,𝑊𝑀,𝑖𝑝𝑠𝑖  and 𝑇2,𝑊𝑀,𝑐𝑜𝑛𝑡𝑟𝑎 = 𝑇2,𝑊𝑀,𝑖𝑝𝑠𝑖 , then 𝑀0(1 − 2𝑒−𝑇𝐼/𝑇1,𝑊𝑀 +
𝑒−𝑇𝑅/𝑇1,𝑊𝑀) ∙ 𝑒−𝑇𝐸/𝑇2,𝑊𝑀 will cancel out on the numerator and the denominator. If we 
assume a normal value for WM CBV (2 mL/100 g parenchyma) on the contralateral 





   (Eq. 5.11) 
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�𝐶𝑊𝑀,𝑖𝑝𝑠𝑖 − 𝐶𝐵𝑉𝑊𝑀,𝑖𝑝𝑠𝑖 ∙ 𝐶𝑏� =  
𝑆𝑊𝑀,𝑖𝑝𝑠𝑖
𝑆𝑊𝑀,𝑐𝑜𝑛𝑡𝑟𝑎
(𝐶𝑊𝑀,𝑐𝑜𝑛𝑡𝑟𝑎 − 𝐶𝐵𝑉𝑊𝑀,𝑐𝑜𝑛𝑡𝑟𝑎 ∙ 𝐶𝑏)   
 (Eq. 5.12) 
𝐶𝐵𝑉𝑊𝑀,𝑖𝑝𝑠𝑖 ∙ 𝐶𝑏 = 𝐶𝑊𝑀,𝑖𝑝𝑠𝑖 −
𝑆𝑊𝑀,𝑖𝑝𝑠𝑖
𝑆𝑊𝑀,𝑐𝑜𝑛𝑡𝑟𝑎
(𝐶𝑊𝑀,𝑐𝑜𝑛𝑡𝑟𝑎 − 𝐶𝐵𝑉𝑊𝑀,𝑐𝑜𝑛𝑡𝑟𝑎 ∙ 𝐶𝑏)       







  (Eq. 5.14) 
 
5.3.3. Imaging Parameters 
 Eighteen acute ischemic stroke patients were consented under an Institutional 
Review Board (IRB) and scanned on a 3T MRI scanner (Achieva, Philips Medical 
Systems, Best, The Netherlands) at the Washington Hospital Center (Washington DC, 
USA) with body coil transmit and 8-channel head coil with sensitivity encoding 
(SENSE). Diffusion tensor images (DTI), fluid attenuated inversion recovery 
(FLAIR), and dynamic susceptibility contrast-based (DSC) perfusion weighted 






Table 5.2. Sequence parameters for sequences acquired on acute ischemic stroke 
patients. 
 
The MT-VASO scan was acquired using a field-of-view of 240x240x140 mm3 
with an imaging matrix of 80x80x40. The data was reconstructed to 256x256 to allow 
for co-registration with other imaging modalities. A 240 ms MT pulse (B1 = 2 μT, 
offset frequency = -40 ppm) was applied before the 1800 inversion pulse to attenuate 
the tissue magnetization at inversion and increase tissue SNR after TI. Other 
parameters include TI/TR/TE = 1081/6000/14 ms, which resulted in a total scan time 
of two minutes and forty-five seconds. The MT-VASO scan is described in detail 
elsewhere (23). 






(ms) Other parameters 
Diffusion Tensor 
Imaging (DTI) 2:15 2x2x3.5  4418 62 
max b-value = 1000, 16 
directions 
Gradient Echo 
(GRE) 2:13 0.7x0.7x3.5 800 12   
Fluid Attenuated 
Inversion 




(MRA) 2:09 0.7x0.7x0.7  23 3.5  FH = 60 mm 
Transverse 
Relaxation Time 




VASO) 2:45 2x2x3.5  6000 14 
TI = 1081 ms,  
MT pulse offset = -40 ppm,  
MT pulse B1 = 2 µT,  
MT pulse duration = 240 ms  
DSC Perfusion 
Weighted Imaging 
(PWI) 1:24 3x3x7  1000 25 
80 acquisitions, 20 mL of 
Magnevist (Bayer HealthCare) 
T1 Post-contrast 1:25 0.7x0.7x7 450 8   
65 
 
A follow-up FLAIR scan was acquired between 20 and 26 hours after the 
acute scan to verify tissue that progressed to infarction and to determine the size of 
the final infarct. The scan parameters of the follow-up FLAIR were identical to that 
of the acute FLAIR scan.  
 
5.4. Data Processing 
All data was processed using in-house written MATLAB® R2008a (The Mathworks, 
Natick, MA) routines. The different MRI modalities, DTI, FLAIR, DSC PWI, and MT-
VASO, were coregistered using CATNAP (Coregistration, Adjustment, and Tensor-
Solving – a Nicely Automated Program, https://masi.vuse.vanderbilt.edu/index.php/, 
developed at Johns Hopkins University, Baltimore, Maryland, USA, maintained by 
Vanderbilt University) (30). After co-registration, mean diffusion weighted (MDW), 
apparent diffusion coefficient (ADC), and fractional anisotropy (FA) parametric maps were 
generated automatically by CATNAP. 
 
5.4.1. MT-VASO data processing 
To allow for comparison between imaging modalities, we interpolated all 
scans to the same resolution (0.94 x 0.94 x 3.5 mm3). Since small reductions in 
VASO signal intensity may be difficult to see with the naked eye, we automated the 
data analysis as follows. First, an in-house written region-growing algorithm was 
generated to create a white matter (WM) mask. Then, a region in contralateral normal 
appearing white matter (CNAWM) was selected. A t-statistic map of the ipsilateral 
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side was calculated to assess difference with respect to CNAWM. The t-statistic was 




      (Equation 5.15) 
Where 𝑥𝑣𝑜𝑥𝑒𝑙  is defined as each voxel’s VASO signal intensity, 𝜇𝐶𝑁𝐴𝑊𝑀  is 
defined as the mean VASO signal intensity over the CNAWM region, 𝜎𝐶𝑁𝐴𝑊𝑀  is 
defined as standard deviation of the VASO signal intensity over the CNAWM region, 
and 𝑛 is defined as the number of voxels in the CNAWM region. In essence, what 
this equation mean is, every voxel was compared to the mean and standard deviation 
of the CNAWM. If the signal intensity of a particular voxel is comparable to 
CNAWM region, then its t-statistic will be close to zero. However, if a voxel contains 
increased microvascular CBV, then its signal intensity will be lower than that of the 
mean of the CNAWM region, which will lead to an increased t-statistic.  
One issue with this method is deep gray matter. Because MT-VASO is an 
inversion recovery sequence, it is highly sensitive to differences in T1. Since deep 
gray matter has a longer T1 than white matter and less MT effect, it results in lower 
signal intensity than white matter for the MT-VASO sequence. This can lead to the 
misunderstanding that deep gray matter has higher CBV changes. To fix this problem, 
we compared the contralateral deep gray matter region with the ipsilateral gray matter 
region. This led to a more reasonable t-statistic value in the deep gray matter. Thus, 
we can use equation 4.6 to identify tissue with increased CBV that may be 
salvageable. Finally, one standard deviation above the mean of the CNAWM of the t-
statistic map was used to threshold the entire t-statistic map, and this was overlaid on 
the original MT-VASO image. Figure 4.2 outlines this process in a flow chart. To 
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interpret these images, one should look for asymmetries between the ipsilateral and 
contralateral side.  
 
 Figure 5.2. Flow-chart of data processing of MT-VASO Scan. 
 
5.4.2. Determination of DWI/PWI/FLAIR lesions 
 Hyperintensities on the mean diffusion weighted images, time to peak 
weighted images, and 24-hour follow-up FLAIR images were manually delineated 
and chosen to represent the diffusion cores, perfusion penumbra, and final infarct in 
MIPAV (Medical Image Processing, Analysis, and Visualization, NIH).  
 
5.4.3. Analysis of Infarct Percentage 
 Further data analysis was performed by analyzing the percentage of voxels 
that progressed to infarction. To determine this, the region of final infarct (determined 
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by the hyperintensity in the FLAIR image) was subtracted from the region of 
hyperintensity on the mean diffusion weighted image to get the region of voxels that 
progressed to infarction. In this region, the number of voxels defined by the time to 
peak (DSC PWI) and MT-VASO scans were divided by the total number of voxels in 
this region to analyze the predictive power of the two techniques.   
 
5.5. Results and Discussion 
5.5.1. Patients 
In total, six females (Age: 66±15 years old) and twelve males (Age: 60±12 
years old) were scanned. Demographics for these patients include twelve African-
Americans and five Caucasians. 
Fifteen patients were scanned within fifteen hours of the ischemic event and 
before thrombolytic treatment (either with tPA or surgery). The other three patients 
were scanned 15 hours, 17 hours, and 21 hours after the ischemic event. One patient 
had severe leukoaraiosis (LA), which interfered with our ability to properly process 
the data because LA changes the T1 relaxation time so this patient was excluded from 






Table 5.3. Background information about each patient. 
















Territory Treatment  
1 50 F 1 hour 37 minutes 26/10 
frontal lobe, 
parietal lobe left MCA IV tPA  










3 57 F 19 hours 7 minutes 18/13 
frontal lobe, 
parietal lobe right MCA  





















5 66 M 3 hours 56 minutes 16/13† frontal lobe left MCA IV tPA 








7 76 M 7 hours 10 minutes 10/1 
pariental 
lobe right MCA IV tPA 







right MCA IV tPA 
9* 76 F 6 hours 12 minutes 22/4 frontal lobe left MCA   IV tPA 
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* This dataset was discarded because this patient had leukoaraiosis, which changed tissue 
T1 and interfered with the MT-VASO analysis. 
† These datasets did not have discharge NIHSS information so 30-day NIHSS information 
was used. 




right MCA   









right MCA Stent 















right MCA IV tPA 




left MCA  
14 49 M 1 hour 33 minutes 15/0 frontal lobe left MCA IV tPA 








16 84 M 3 hours 35 minutes 21/5 
frontal lobe, 
parietal lobe right MCA IV tPA 







left MCA IV tPA 










 Figure 5.3 shows the results for expected changes in the VASO signal based 
on 30% incremented increases of white matter microvascular blood volume. In 
Donahue et al, assumptions were made on the size of the different compartments 
(white matter, gray matter, and CSF) (19). However, in our particular application of 
this technique, because of the partial voluming issue with gray matter and CSF and 
given the limits of our resolution, we limit our analysis to white matter. Thus, our 
simulations assumed that voxels contain 100% white matter. The simulations showed 
that for white matter, microvascular CBV increases of 30%, 60%, 90%, 120%, and 
150%, respectively, will manifest in reductions of the VASO signal intensity from 
baseline CBV conditions by 1%, 2%, 3%, 4%, and 5%, respectively.   
 
Figure 5.3. Simulated decrease in MT-VASO signal intensity due to different 
increases in microvascular cerebral blood volume (CBV). 
 Because of the time-sensitive nature of acute ischemia patients, I was only 
able to scan for 2 minutes and 45 seconds, which gave me a resolution of 2x2x3.5 
mm3. However, at this resolution, partial voluming effects (PVE) do not allow 
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adequate resolution of gray matter so we restrict our analysis to white matter for 
patients.  
 
5.5.3. Patient 1 
Figure 5.4 shows data from a patient who was scanned one hour and thirty-
seven minutes after last seen normal. The acute FLAIR scan shows no visible signs of 
infarct. The diffusion weighted scan shows a hyperintensity in the left hemisphere 
(radiological convention used in display) that spans across multiple slices indicating 
an area that may eventually progress to infarction. Time-to-peak weighted images 
show a region below the diffusion lesion that may progress to infarction if left 
untreated. The processed VASO images highlight a region similar to the 
hyperintensity on the time to peak weighted map. The follow-up FLAIR scan 
acquired 24 hours after the acute scans show evidence of infarction where the 




Figure 5.4. Images from patient 1, scanned 1 hour 36 minutes after last seen normal. 
In this particular case, the processed VASO image is highly useful in showing 
asymmetries in multiple slices that could be due to increases in microvascular CBV 
caused by the occlusion in this patient. Additionally, it is interesting to notice 
asymmetries in the processed VASO map in the region where there are 
hyperintensities on the TTP-weighted images. Furthermore, the region of elevated 
time to peak and increased microvascular CBV do not appear to have progressed to 
infarction based on the follow-up FLAIR acquired one day later. Because this patient 
was treated with IV-tPA, one hypothesis would be that blood flow was restored to the 
regions of elevated microvascular CBV before blood vessels in that region collapsed 
allowing cerebral perfusion to be restored before cytotoxic edema occurred. Also, the 
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hypothesis is that the regions are still viable when CBV is increased, which would be 
confirmed by this result. 
 
5.5.4. Patient 2 
Figure 5.5 shows data from a patient who was scanned two hours and eleven 
minutes after they were last seen normal. The acute FLAIR scan shows no evidence 
of changes in T2 yet. However, a hyperintensity can be seen in the acute DWI. The 
DSC time-to-peak weighted image shows large regions of perfusion abnormalities. 
The DSC CBV weighted image shows elevated microvascular CBV in the ipsilateral 
region of the patient. The processed VASO image shows abnormalities in the same 
location of increased CBV. The follow-up FLAIR scan shows a lesion where the 





Figure 5.5. Images from patient 2, who was scanned 2 hours and 11 minutes after last 
seen normal. 
 In this second patient, the VASO image correlates well with the gadolinium-
based dynamic susceptibility contrast weighted cerebral blood volume and time to 
peak parametric maps. Asymmetries in the VASO image are noted in regions with 
increased TTP and hyperintensities in the CBV parametric maps.  
 
5.5.5. Patient 3 
Figure 5.6 shows data from a patient who was scanned nineteen hours and 
seven minutes after she was last seen normal. In this patient, the acute FLAIR scan 
shows a hyperintensity, which is indicative of T2 relaxation time increases. The acute 
mean diffusion weighted scan shows larger region of hyperintensity than the acute 
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FLAIR scan, which may imply that the ischemic region is larger than the infarct and 
more infarction may occur. The acute time to peak weighted scan shows two distinct 
regions: a core region that is in the same location as the diffusion lesion, as well as a 
penumbral region larger than the region of restricted diffusion. The DSC CBV image 
shows a region of reduced CBV where the blood vessels may have already collapsed 
and is not being perfused anymore. Our processed VASO map shows a distinct 
asymmetry. The 24-hour follow-up FLAIR scan shows a region of infarction as large 
as the region of perfusion deficit. 
 
Figure 5.6. Images from patient 3, scanned 19 hours and 7 minutes after last seen 
normal. 
The data from this particular patient shows that our technique may only be 
useful during the hyperacute phase of ischemia. After changes in the relaxation times 
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(T1 and T2) have begun to occur, it is difficult to distinguish these changes from CBV 
changes. Additionally, changes of T1 and T2 lead to the collapse of assumptions 
surrounding the model derived in section 5.3.2.  
 
5.5.6. Group Analysis 
Figure 5.6 shows the percentage of voxels that progressed to infarction. 
Patients 5 and 14 show no voxels that progressed to infarction based on the penumbra 
determined by the PWI.  
 
Figure 5.7. Percentage of Penumbral Voxels in White Matter that Progress to 
Infarction. 
Except for patient 15, the results show that the area at risk of infarction judged 
from the VASO analysis is more predictive than that from the PWI/DWI mismatch. 
However, the VASO method is more tedious than the PWI approach. 
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There are a number of limitations with this study. First, we only investigated 
18 patients. To determine if this technique is useful clinically, a study on a much 
larger scale would need to be conducted. Second, a limitation of this technique is its 
dependence on T1. This causes problems if T1 changes in stroke patients occur, which 
typically occurs if the blood clot is not treated in time. Additionally, because many 
stroke patients are older, other pathologies such as leukoaraiosis that causes T1 




We developed a new method to image possible increases in microvascular cerebral 
blood volume and T1 in white matter. MT-VASO can add information about regions of 
increased CBV, which may imply regions at-risk-of infarction in the perfusion penumbra. 
Drawbacks of this technique include (1) sensitivity to T1 changes, which when past a certain 
time window could lead to a false interpretation of the data, and (2) limited analysis to white 
matter and deep gray matter because of insufficient signal-to-noise and resolution (in a 
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Chapter 6: Application of Steady State Pulsed CEST to Image Acute 
Ischemic Stroke Patients 
 
6.1. Abstract 
 It is widely known that thrombolytic therapy (intravenous tissue plasminogen 
activator), if given quickly after the occurrence of ischemia, can significantly improve 
clinical outcome. Currently, to evaluate whether a patient is a candidate for receiving 
thrombolytic therapy, the diffusion-perfusion mismatch based on magnetic resonance 
imaging can be used. However, the region of reduced perfusion that is at risk of infarction is 
frequently overestimated with current gadolinium-based perfusion weighted imaging, due to 
part of the area being due to benign oligemia. This can result in patients being taken for 
aggressive therapy when it may not actually be needed. Tissue pH reductions are expected to 
be a better marker for at risk tissue in acute ischemia patients that is still salvageable because 
they reflect impaired aerobic metabolism. In this chapter, we explore using a modified 
steady-state pulsed chemical exchange saturation transfer imaging sequence to analyze pH 
changes in acute ischemic stroke patients. 
 
6.2. Introduction 
Stroke, the third leading cause of death and leading cause of disability, affects 
approximately fifteen million people each year in the world (1). Acute ischemic stroke, 
caused by the occlusion of cerebral blood vessels by an arterial embolus or thrombus, 
accounts for approximately 85% of cases (2). A number of studies have shown that 
thrombolytic treatment with intravenous tissue plasminogen activator (tPA) to restore blood 
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flow can be useful for reducing tissue infarction when given within the first 3-6 hours post-
onset (3). However, the benefit of tPA must be weighed against the risk of intracranial 
hemorrhage (4-6), which occurs in approximately 6% (7) of cases in which patients are 
treated with tPA and frequently leads to irreversible damage. The ability to quickly and 
accurately assess whether patients have salvageable ischemic tissue is critical to improving 
functional outcome and minimizing long-term disability. 
tPA has a number of contraindications for its usage (8). One of the most important 
contraindications before giving tPA is evidence of hemorrhage, which can be assessed by CT 
or MRI. Of these, CT is faster and more convenient, but MRI is much more versatile and can 
offer other contrasts. Diffusion-weighted imaging (DWI) and dynamic susceptibility 
contrast-based perfusion-weighted imaging (PWI) are MRI-based scans that are frequently 
used to evaluate whether a patient would be a good candidate for tPA. Specifically, DWI is 
able to portray regions where disruption of cellular membrane potential has occurred. This 
corresponds to tissue that is likely to progress to infarction. DSC PWI employs the use of an 
exogenous gadolinium-based tracer; following the tracer as a function of time allows for 
qualitative assessment of mean transit time (MTT), time to peak (TTP), cerebral blood flow 
(CBF), and cerebral blood volume (CBV) (9, 10). The parametric maps derived from the 
PWI scan can be used to determine regions of the brain that are functionally intact but at risk 
of infarction if the ischemia is not reversed. Patients with these regions are ideal candidates 
for thrombolytic treatment with tPA. Thus, the DWI/PWI mismatch, or “perfusion penumbra,” 
can be used in principle to assess the extent of tissue that is ischemic but has not yet 
proceeded to infarction. However, the actual ischemic penumbra, i.e. region at risk of 
infarction, is not straightforward to identify from the DWI/PWI mismatch. There have been 
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numerous reports that the penumbra defined by PWI frequently overestimates the true region 
at risk (11). This is because reductions in perfusion imaged with PWI actually cover two 
regions: (1) an oligemic region that contains benign reductions in blood flow that will 
eventually revert on its own to normal perfusion, and (2) a region that, if left untreated, will 
progress to infarction.  Recent evidence has shown that intracellular pH is reduced in regions 
of the brain with cerebral blood flow low enough such that functional integrity is maintained, 
but cellular respiration changes from aerobic respiration (with oxygen) to anaerobic 
respiration, which leads to a build up of lactic acid and reduced pH. 
Chemical exchange saturation transfer (CEST) MRI has recently been shown to be 
sensitive to changes in pH (12-15), especially the use of so-called amide proton transfer 
(APT) MRI, in which the combined signals of amide protons in brain tissue are detected via 
their exchange with the water signal detected by MRI. Preclinical ischemia models have 
confirmed that APT may predict areas that go to infarction better than PWI or DWI (15).  
Our hypothesis is that patients with regions of reduced blood flow and reduced pH 
and no diffusion impairment have tissue that is at risk of infarction if not properly reperfused. 
Here we explore the feasibility of using a Steady State Pulsed Chemical Exchange Saturation 
Transfer (SSP-CEST) to visualize tissue at risk of infarction in acute cerebral ischemia 
patients in a clinically feasible time frame. CEST offers several benefits to current methods 
for looking at the ischemic penumbra: (1) CEST is a non-invasive technique. Numerous 
studies have linked occurrences of nephrogenic systemic fibrosis (NSF) to use of 
gadolinium-based contrast agents; (2) CEST will not highlight regions of benign oligemia 
because pH contrast is derived from cellular anaerobic respiration caused by reduced cerebral 
blood flow making it potentially more accurate than the currently used DSC-PWI.  
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6.3. Materials and Methods 
CEST MRI generally involves the acquisition of a so-called saturation spectrum or Z-
spectrum (16) in which the ratio of the saturated (Ssat) and unsaturated (S0) water signals is 
plotted as a function of saturation frequency difference (Δω) with water. Because the 
exchangeable protons tend to resonate downfield (at higher frequency) from water and in an 
effort to remove the symmetric effects from direct water saturation (DS), CEST data are 
commonly analyzed using asymmetry analysis with respect to the water frequency set at 
Δω=0 and normalized to unsaturated signal (S0). Defining the MT ratio (MTR) as 1 – Ssat/S0, 
this gives: 
𝑀𝑇𝑅𝑎𝑠𝑦𝑚𝑚𝑒𝑡𝑟𝑦(∆𝜔) = 𝑀𝑇𝑅(∆𝜔) + 𝑀𝑇𝑅(−∆𝜔) =
𝑆𝑠𝑎𝑡(−∆𝜔)−𝑆𝑠𝑎𝑡(∆𝜔)
𝑆0
   (Equation 
6.1) 
Obviously such an analysis will not be completely correct if any MT effects occur 
upfield from water. This unfortunately is the case in vivo where MT effects of semi-solid 
tissue components (conventional MT contrast or MTC) cause a strong, broad (tens of ppm) 
and asymmetric component to the Z-spectrum (17, 18). To complicate matters, a recent study 
of glycosaminoglycans (19) indicated the presence of an additional upfield MT effect. This 
was attributed to nuclear Overhauser enhancements (NOE) in the NMR spectral range for 
aliphatic and olefinic protons, ranging from 0-5 ppm in the proton spectrum or -5 to 0 ppm in 
the Z-spectrum (20-22). This was later confirmed by others (23, 24). Assuming removal of 
the DS, the asymmetry thus needs to be described by: 
𝑀𝑇𝑅𝑎𝑠𝑦𝑚𝑚𝑒𝑡𝑟𝑦(∆𝜔) = 𝑀𝑇𝑅𝑎𝑠𝑦𝑚𝑚𝑒𝑡𝑟𝑦𝐶𝐸𝑆𝑇 (∆𝜔) + 𝑀𝑇𝑅𝑎𝑠𝑦𝑚𝑚𝑒𝑡𝑟𝑦𝑀𝑇𝐶 (∆𝜔) + 𝑀𝑇𝑅𝑎𝑠𝑦𝑚𝑚𝑒𝑡𝑟𝑦𝑁𝑂𝐸 (∆𝜔)  
         (Equation 6.2) 
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Notice that the MTC effects in (semi)-solid tissue components originate from fast 
dipolar transfer of NOEs through spin diffusion followed by transfer to water and are hidden 
in a broad solid-state spectrum. The sharper NOE-based signals measured in the aliphatic and 
olefinic spectral range, on the other hand, are from mobile macromolecular components with 
finite linewidth (20, 21). The fact that signals originating from non-exchangeable protons 
appear in the Z-spectrum indicates the presence of a transfer mechanism to water, which has 
been attributed to either direct through-space dipolar transfer (19, 24) or a relay mechanism 
via exchangeable protons (22). Irrespective of this, the opportunity to detect NOE-relayed 
signals based in mobile macromolecules offers an opportunity to study such compounds non-
invasively with high sensitivity in vivo.  
One problem to address is how these NOEs can be detected without too much MTC 
interference. Fortunately, the relative contributions of MTC and CEST effects can be tuned 
(25, 26) by varying saturation pulse length (tsat) and field strength (B1). We recently showed 
that this approach can be optimized to detect slower transfer processes, such as due to 
exchanging amide protons and NOE-relayed effects, with minimal MTC interference (23). 
This can be accomplished by performing a low-power steady state pulsed CEST experiment 
and removing the DS contribution using a Lorentzian difference analysis (LD). 
 
6.3.1. Simulations 
Simulations were performed using the 3-pool model (a = bulk water pool, b = 
bound water pool, and c = amide proton pool) of the chemical exchange modified 
Bloch equations (Equations 6.1-6.9) (27). Analysis was performed of how much 
amide proton exchange rate and proton transfer ratio (PTR) drops when tissue 
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acidosis occurs. Recent research from positron emission tomography (PET) and as 
well as other research techniques have shown that during ischemia, pH can drop to 
6.4 to 6.6 if serum glucose is still in the normal range (28). However, with plasma 
hyperglycemia, tissue pH can drop down to 6.0 or 6.1 because of continued delivery 
of glucose and production of lactate during anaerobic glycolysis (28). Furthermore, 
when pH drops to 5.9, tissue infarction occurs (29). Both gray matter and white 
matter values were simulated. Table 6.1 summarizes a list of parameters that were 
used for this simulation.  
𝑑𝑀𝑥𝑎
𝑑𝑡
= −(𝜔𝑎 − 𝜔)𝑀𝑦𝑎 − 𝑘2𝑎𝑀𝑥𝑎 + 𝐶𝑏𝑀𝑥𝑏 + 𝐶𝑐𝑀𝑥𝑐   (Equation 6.3) 
𝑑𝑀𝑥𝑏
𝑑𝑡
= −(𝜔𝑏 − 𝜔)𝑀𝑦𝑏 − 𝑘2𝑏𝑀𝑥𝑏 + 𝐶𝑎𝑏𝑀𝑥𝑎     (Equation 6.4) 
𝑑𝑀𝑥𝑐
𝑑𝑡
= −(𝜔𝑐 − 𝜔)𝑀𝑦𝑐 − 𝑘2𝑐𝑀𝑥𝑐 + 𝐶𝑎𝑐𝑀𝑥𝑎     (Equation 6.5) 
𝑑𝑀𝑦𝑎
𝑑𝑡
= (𝜔𝑎 − 𝜔)𝑀𝑥𝑎 − 𝑘2𝑎𝑀𝑦𝑎 + 𝐶𝑏𝑀𝑦𝑏 + 𝐶𝑐𝑀𝑦𝑐 − 𝜔1𝑀𝑧𝑎   (Equation 6.6) 
𝑑𝑀𝑦𝑏
𝑑𝑡
= (𝜔𝑏 − 𝜔)𝑀𝑥𝑏 − 𝑘2𝑏𝑀𝑦𝑏 + 𝐶𝑎𝑏𝑀𝑦𝑎 − 𝜔1𝑀𝑧𝑏    (Equation 6.7) 
𝑑𝑀𝑦𝑐
𝑑𝑡


















𝑐 − 𝑘1𝑐𝑀𝑧𝑐 + 𝐶𝑎𝑐𝑀𝑧𝑎 + 𝜔1𝑀𝑦𝑐    (Equation 6.11) 
Where 𝑀𝑥𝑖 ,𝑀𝑦𝑖 , and 𝑀𝑧𝑖  (i = a, b, c) represents the magnetization in the x, y, and z 
directions for pool i , T1i and T2i (i = a, b, c) is the longitudinal and transverse relaxation 
times in the absence of exchange for pool i, ω is the RF irradiation frequency, ωi (i = a, b, c) 
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is the Larmor frequency of pool i, ω1 is the nutation rate of the RF irradiation, Cab is the 
transition rate of pool A protons leaving pool A and entering pool B, and Cac is the transition 
rate of pool A protons leaving pool A and entering pool C. Due to mass conservation, the 








𝑎)𝐶𝑐          (Equation 6.13) 
𝐶𝑎 = 𝐶𝑎𝑏 + 𝐶𝑎𝑐         (Equation 6.14) 
Where 𝑀0𝑖  is the equilibrium magnetization for pool i (i = a, b, c) that are proportional 
to the concentrations of the three pools, and equations for k1i (i = a, b, c) and k2i (i = a, b, c) 












Table 6.1 shows parameters used in the simulations. 
Table 6.1. Simulation Parameters 





Pool (pool b) 
Amide Proton 
Pool (pool c) 
T1 (ms) 1209(30) 758(30) 1200 590ǂ 
T2 (ms) 70.8(30) 81(30) 0.011(18) 33 
Exchange Rate, 
Cab and Cac (1/s) 
0 0 14 28(12) 
Chemical Shift 
(ppm) 
0 0 0 3.5(12) 
ǂ This value could not be found in literature for the 3T field strength; thus, it was 
estimated using published values at 4.7T. At 4.7T, R1,amide = 1.3 s (T1,amide = 0.77 s) 
(31) 
 A simulation (figure 6.1) of the steady state pulsed CEST sequence over a 
variety of CEST saturation pulse parameters (using a sinc-gauss saturation pulse) 
shows that the pulse duration and pulse B1 that maximize the CEST effect 17 ms and 









Figure 6.1. Analysis of Optimal CEST Saturation Pulse Parameters Based on 3-pool 
Bloch-McConnell Simulation for (A) Gray Matter and; (B) White Matter  
However, when using this combination to simulate a z-spectra, it was found 
that a 17.5 ms pulse is not selective enough and leads to a significant amount of direct 
saturation, particularly around the irradiation offset frequency of interest (ω = +3.5 
ppm). This makes using the Lorentzian Difference Analysis (LDA) to process z-
spectra quite difficult because the resulting z-spectrum is not in the form of a 
Lorentzian (23). Therefore, further investigation was performed to find a more 
selective saturation pulse and a saturation pulse B1 that would yield a z-spectrum with 
a lineshape that could be fit with a Lorentzian and could maximize the CEST effect. 
Further analysis showed that a sinc-gauss saturation pulse duration of 25 ms and a 
saturation pulse B1 of 1 µT fulfills this criteria.  
Using this optimal saturation pulse duration (25 ms) and optimal saturation 
pulse B1 (1 µT), it was explored how pH changes the exchange rate of amide protons 
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and how this affects the APT effect. Using the base-catalyzed equation (Equation 
6.15) determined by Zhou et al using phosphorus spectroscopy, we substituted several 
relevant pHs (6.0 to 7.4, increment 0.1) for ischemia and calculated the exchange rate 
for those respective pHs (12). These exchange rates were evaluated in the context of 
the 3-pool model to see how the APT effect changes for reductions in pH. 
 𝐶𝑎𝑐 = 5.57 ∗ 10𝑝𝐻−6.4      (Equation 6.17) 









Figure 6.2. Simulation of 3-pool Bloch-McConnell Equation for Changes in pH (A) in a 
voxel with 100% Gray Matter and (B) in a voxel with 100% White Matter. 
Futhermore when using MRI to acquire images of the brain, one of the issues that we 
frequently run into is partial volume effects. Because the signals that we are trying to detect 
are very small (based on simulations, on the order of 0.2-1.3%), it is important to acquire 
larger voxels to increase the signal-to-noise ratio (SNR). However, when larger voxels are 
acquired, one voxel has multiple compartments including gray matter, white matter, 
cerebrospinal fluid (CSF), and blood. When a voxel has multiple compartments, we have 
partial volume effects and need to account for this in our model. In order to simulate the APT 
signal in cases where partial volume effects leads to multiple compartments in each voxel, 
we simulated a voxel with 20% gray matter and 80% white matter. Results from this 


























7.4 55.7 1.60 0% 1.11 0% 1.21 0% 
7.3 44.2 1.50 -5.92% 1.05 -6.05% 1.14 -6.02% 
7.2 35.1 1.38 -14.00% 0.96 -14.23% 1.04 -14.16% 
7.1 27.9 1.22 -23.60% 0.85 -23.91% 0.92 -23.83% 
7.0 22.1 1.06 -33.88% 0.73 -34.23% 0.80 -34.14% 
6.9 17.6 0.90 -44.00% 0.62 -44.37% 0.68 -44.27% 
6.8 14.0 0.75 -53.36% 0.52 -53.73% 0.56 -53.63% 
6.7 11.1 0.61 -61.64% 0.42 -62.00% 0.46 -61.90% 
6.6 8.8 0.50 -68.72% 0.35 -69.06% 0.38 -68.97% 
6.5 7.0 0.41 -74.66% 0.28 -74.97% 0.30 -74.89% 
6.4 5.6 0.33 -79.56% 0.23 -79.84% 0.25 -79.77% 
6.3 4.4 0.26 -83.56% 0.18 -83.81% 0.20 -83.75% 
6.2 3.5 0.21 -86.80% 0.14 -87.03% 0.16 -86.97% 
6.1 2.8 0.17 -89.41% 0.12 -89.62% 0.13 -89.57% 
6.0 2.1 0.14 -91.52% 0.09 -91.70% 0.10 -91.65% 
 
6.3.2. Phantom Creation 
 A 10% BSA phantom was created by dissolving 42 g of BSA (66.5 kD; 
Sigma–Aldrich, St Louis, MO) in 420 mL of phosphate-buffered solution, giving a 
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1.5 mM solution. The resulting mixture was poured into eight 50-mL Falcon tubes 
and the pH was titrated (Seven Compact, Mettler Toledo) to 5.70, 6.01, 6.33, 6.61, 
7.01, 7.29, 7.60, and 8.00. A ninth tube was filled with PBS as a control. A solution 
of 0.2% sodium azide (Sigma-Alderich, St. Louis, MO) was added to each of the nine 
tubes to preserve the phantoms. All tubes were capped and sealed with Parafilm (Lab 
Depot, Dawsonville, GA, USA). The phantoms were then placed in a larger container 
(The Container Store, Plano, TX, USA), and the large container containing the eight 






Figure 6.3. Images of pH phantoms (A) Arrangement of phantoms asymmetrically in large 





6.3.3. Phantom Scan  
The phantoms were scanned on a 3T Philips Achieva scanner using a 32-
channel receive only SENSitivity-Encoded (SENSE) head coil to detect the signal. 
For the phantom scan, a steady state pulsed CEST sequence was run with the 
following parameters: saturation pulse duration = 25 ms, saturation pulse B1 = 1 µT. 
The spatial resolution was 4.4x4.4x4.4 mm3. A random number generator was used to 
generate the order of frequencies that the scan was run. The randomly ordered 
saturation frequency offsets (in ppm, relative to the water frequency set to 0) were 
unsaturated (unsat), unsat, -5.6, -10, -0.5, 7, 14.4, unsat, 10.4, -0.4, -2.7, -11.4, -0.9, 
unsat, -11.6, -3.3, -6, 1.1, -7.4, unsat, -5.2, 6.4, -1.4, 11.2, -5.8, unsat, 12.4, 4.9, -1.9, 
5.7, -3.1, unsat, -10.6, -1.3, -4.3, 12, -32, unsat, -3.9, -4.4, -28, -6.8, -9.6, unsat, -8.8, -
0.3, 3.9, -4.6, 36, unsat, 0.7, -3, 4.5, 0.5, 3.7, unsat, -14.4, 14.2, 3.2, 5.6, 3.8, unsat, 4, 
-7.2, 3.5, 9, -0.8, unsat, 8, -3.2, 40, -2.9, -1.6, unsat, -15, -14.2, -18, -24, 5, unsat, -5, 
11.4, 5.3, 6.6, -8.4, unsat, -4.5, -12.6, 0.3, 5.8, 3.3, unsat, 1.7, 4.2, -9.2, 5.9, 13.8, 
unsat, 11.6, -9.8, -2.2, -14.6, 2.6, unsat, -3.6, -13.6, -0.7, 10, 0.8, unsat, -2, 2.3, -12, -
1.7, 9.8, unsat, -5.1, -3.4, -1.5, 5.1, -2.8, unsat, 6, 4.4, -4.8, 4.1, 1.5, unsat, 4.8, -5.9, 
1.6, -7.6, 0.1, unsat, 8.2, -10.2, 3.4, -13.8, 15, unsat, 1.4, 7.6, 9.2, -2.3, -2.4, unsat, 
12.8, 14.8, 6.2, 1.8, 1.9, unsat, -3.5, 8.8, -9, -11.2, 2.5, unsat, -6.4, 8.6, 0.2, -36, -13, 
unsat, -4, 2.9, -11.8, -10.4, -1, unsat, 32, 7.8, -4.1, -13.2, 3.1, unsat, 5.2, -8.6, 5.4, 18, -
14, unsat, 20, -3.7, 3, 9.4, 0.9, unsat, 2.2, 0, -0.2, 12.6, -8.2, unsat, 9.6, 11.8, 0.6, -8, 
14, unsat, 5.5, 13.2, 12.2, 7.4, -0.1, unsat, 14.6, 0.4, -7.8, -12.2, -12.4, unsat, -5.5, 1.3, 
13, -11, 1, unsat, -1.8, -9.4, 2.1, 11, -4.9, unsat, 6.8, 28, 2.4, -16, -5.4, unsat, 2, -0.6, -
6.6, -13.4, -20, unsat, 3.6, -3.8, 24, -5.3, -4.2, unsat, 2.8, 10.6, 13.6, -2.1, -2.6, unsat, 
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13.4, 16, 4.6, -4.7, 10.8, unsat, -7, -12.8, 4.3, 7.2, -14.8, unsat, 1.2, -10.8, 2.7, -1.2, -
2.5, unsat, -1.1, -40, -5.7, 8.4, 4.7, unsat, 10.2, -6.2, unsat, unsat. Total acquisition 
time was 97 minutes 59 seconds. The unsaturated references were acquired using the 
same sequence as the saturated volume (including the TR) except with the RF 
saturation pulse turned off.  
 
6.3.4. CEST Baseline Correction 
 It was observed that the intensive gradient switching in this sequence led to a 
baseline signal intensity drift that affected the measured CEST effects. To measure 
such scanner drift, a multishot gradient echo scan (7 lines of k-space acquired each 
shot) was run continuously for 65 minutes on a standard issue Philips “blue head” 
phantom, which was subsequently used to verify drift on two of our 3T Philips 
scanners (XMR and MR1). To quantify this drift, signal intensities were normalized 
to the first point and multiplied by 100 to convert it into a percentage.  
In order to correct for this drift in the pH phantoms, we acquired S0 volumes 
every five frequencies (see frequency list in section 5.3.3). To perform baseline 
correction, we fitted a smoothed spline to the S0 points as a function of scan time 
elapsed on a voxel-wise basis. Then between each pair of S0 points, the spline fit was 
linearly interpolated, and this information was used to correct the data acquired. This 






6.3.5. Healthy Volunteers 
 Three healthy volunteers (Age: 45 ± 18) were consented and scanned on a 
Philips Achieva 3T MRI scanner using a 32-channel SENSE receive only head coil 
for signal reception. Demographics of healthy volunteers include two females and one 
male, one Asian and two Caucasians. Healthy volunteers received a FLuid Attenuated 
Inversion Recovery (FLAIR) scan, a Gradient Recalled Echo (GRE) scan, a steady-
state pulsed CEST, a Magnetic Resonance Angiography (MRA) scan, and a Diffusion 
Tensor Imaging (DTI) scan. 
 
6.3.6. Patients 
Five acute stroke patients (Age: 55 ± 23) were consented and scanned on a 
Philips Achieva 3T MRI scanner using a 32-channel SENSE receive only head coil. 
One dataset had to be repeated due to excessive motion. Patients received the 
following scans: 1) Acute FLAIR, to confirm evidence infarction; 2) DTI, to see if 
there are regions that will progress to infarction; 3) SSP-CEST, to study pH changes; 
and 4) PWI, to study the perfusion diffusion mismatch. A follow-up FLAIR was 
acquired at least 24 hours after the initial scan. Two patients did not receive a follow-
up FLAIR scans because they were discharged from the hospital before a follow-up 
could be acquired and could not be reached. Other relevant patient information can be 
found in Table 5. 
Upon admission, patients were evaluated with the National Institutes of 
Health Stroke Scale (NIHSS), a tool used by physicians to quantify the degree of 
impairment of stroke patients. The NIHSS rates patients over eleven categories 
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including level of consciousness, horizontal eye movement, visual field test, facial 
palsy, motor arm, motor leg, limb ataxia, sensory, language, dysarthria, extinction and 
inattention. Most categories are rated from zero to four (some are zero to two, some 
zero to three), where zero represents normal function and four represents severe 
impairment. Scores from each category are summed together to arrive at the 
comprehensive NIHSS score. The maximum score is 42, and the minimum score is 0. 
Table 6.3. Relevant Patient Information. 











1* 86 F 10 62 hours Right MCA hypertension 

















* Patients that did not receive follow-up FLAIR scans. 
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† This patient was scanned twice due to excessive motion. This is the time of the first 
scan. 
 
6.3.7. Imaging Parameters 
Individual scan parameters were: FLAIR: 1.1 mm in-plane resolution, 4.4 mm 
slice thickness, TE/TR/TI = 100/7000/2500 ms; DTI: 2.2 mm isotropic voxels, b-
value = 700 mT/m, 32 directions, TE/TR = 71/7043 ms, 70 slices acquired; PWI: 
2.2x2.2x4.4 mm3 voxels, TE/TR = 40/1500 ms, 80 dynamics acquired, 22 slices 
acquired. SSP-CEST was used to acquire images weighted by pH (16). SSP-CEST 
parameters include: 4.4 mm3 isotropic voxels, saturation pulse duration = 25 ms, 
saturation pulse B1 = 1 µT, TR/TE = 65/7 ms, 35 slices acquired. A binomial 
excitation pulse (1-2-1) with flip angle 12° was used for fat suppression by exciting 
only water spins while leaving fat spins unperturbed. One patient (patient 1) received 
a SSP-CEST scan that had a resolution of 2.2 mm2 in plane, but 4.4 mm slice 
thickness. Pulsed CEST images were acquired at 61 frequencies: ±9 , ±7 , ±5 , ±4.5 , 
±4.3 , ±4.1, ±3.9 , ±3.7, ±3.5, ±3.3, ±3.1, ±2.9, ±2.7, ±2.5, ±2.0, ±1.5, ±1.4, ±1.3, ±1.2, 
±1.1, ±1.0, ±0.9, ±0.8, ±0.7, ±0.6, ±0.5, ±0.4, ±0.3, ±0.2, ±0.1, and 0 ppm (relative to 
the water frequency). Four unsaturated volumes were acquired with the same 
sequence with the RF saturation pulse turned off and averaged together to get S0. 
Additionally, a navigator was acquired to correct for physiological noise (32). Total 
scan time for pulsed CEST was 10 minutes 34 seconds. The steady state pulsed CEST 




Figure 6.4. Steady-state pulsed CEST Pulse Sequence with navigator. 
 
6.4. Data Processing 
All data was processed using in-house written MATLAB® R2008a (The Mathworks, 
Natick, MA) routines. The different MRI modalities, DTI, FLAIR, DSC PWI, and MT-
VASO, were coregistered using CATNAP (Coregistration, Adjustment, and Tensor-
Solving – a Nicely Automated Program, https://masi.vuse.vanderbilt.edu/index.php/, 
developed at Johns Hopkins University, Baltimore, Maryland, USA, maintained by 
Vanderbilt University) (33). After coregistration, mean diffusion weighted (MDW), apparent 
diffusion coefficient (ADC), and fractional anisotropy (FA) parametric maps were generated 
automatically by CATNAP. Additionally, the images were skull-stripped using the brain 
extraction algorithm from FSL (34). 
 
6.4.1. Pulsed CEST data processing 
The pulsed CEST data were processed on a voxel-wise basis as follows: 1) 
The center frequency shift map was determined by fitting a Lorentzian lineshape to a 
103 
 
sub-spectrum of the following frequencies: ±9 , ±7 , ±5, ±1.0, ±0.9, ±0.8, ±0.7, ±0.6, 
±0.5, ±0.4, ±0.3, ±0.2, ±0.1, and 0 ppm (known as the Lorentzian Difference Analysis 
(LDA)) (23). 2) Using the center frequency shift map, the z-spectra were shifted so 
that the center frequency of each voxel was at 0 ppm. 3) Next, magnetization transfer 
ratios, (MTR) at +3.5 ppm and -3.5 ppm were calculated by averaging signal 
intensities at ±3.7, ±3.5, and ±3.3 ppm.  4) MTR asymmetry (MTRasymmetry(+3.5 ppm)) 
maps were calculated by subtracting MTR(-3.5 ppm) from MTR(+3.5 ppm) (12). 5) 
Finally, APT and NOE maps  were calculated by averaging the LDA(+3.3, +3.5, +3.7) 
and LDA(-2, -2.5, -2.7, -2.9, -3.1, -3.3, -3.5, -3.7, -3.9, -4.1, -4.5, -5), respectively.  
 
6.4.2. Determination of DWI lesions 
 Voxels exhibiting signal intensity greater than one and a half standard 
deviations above the mean of the mean diffusion image were designated as diffusion 
lesions.  
 
6.4.3. Perfusion Weighted Imaging Data Processing 
PWI data were computed on a voxel-wise basis to generate a time to peak 
(TTP) map for each patient. For one stroke patient, the TTP map was further 
processed by generating a TTP delay map using the contralateral normally perfused 
tissue as reference (35). Furthermore, cutoffs of the TTP delay map were applied at 
≥2, ≥3, ≥4, ≥5, and ≥6 seconds. These cutoffs were chosen because recent 
publications comparing PET and MR methods for identifying penumbral blood flow 
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have confirmed that a TTP delay of four seconds corresponds closely to the PWI 
penumbra (35-37). The other stroke patient did not have a pH-weighted lesion so we 
did not perform this analysis for that patient. 
 
 6.4.4. Estimation of Infarct Percentage 
To study how the pH penumbra estimates tissue at risk of infarction 
differently than the PWI penumbra, we applied two thresholds (MTRasymmetry(+3.5 
ppm) ≤ -2 and MTRasymmetry(+3.5 ppm) ≤ -3) to determine the pH penumbra for the 
stroke patient that had a pH lesion and overlapped the pH penumbra mask with maps 





6.5.  Results and Discussion 
6.5.1. CEST Baseline Correction 
Results of the 65 minute scan to analyze scanner drift can be seen in figure 6.5. 
 
Figure 6.5. Scanner Drift (A) XMR (B) MR1 
 It can be seen that scanner drift can potentially shift relative signal intensities 
by ±1%. However, this is problematic because small changes in pH are reflected in 




Figure 6.6. CEST Baseline Correction: Comparison of Corrected and Uncorrected for 
pH 6.3 10% BSA phantom. (A) S0 points and Fitted Spline (B) Corrected and 
Uncorrected Acquired Data (C) Uncorrected and Baseline Corrected CEST spectra  
(D) Uncorrected and Corrected LDA 
 The proposed method for CEST baseline correction was applied to pH 
phantoms and worked well to correct baseline inconsistencies. In figure 6.6A, the S0 
points are displayed as blue points and a smooth spline (red line) is fitted through 
those points as a function of time. In figure 6.6B, the uncorrected and corrected data 
are displayed in blue and red, respectively. Notice how the blue line drifts down 
approximately 5%. The baseline CEST correction method corrects this to ensure that 
normalized S0 intensities remain at 100%. Figure 6.6C shows the CEST spectra 
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before and after baseline correction. The uncorrected data (blue line) is noticeably 
noisier towards the ends (points greater than 10 ppm and less than -10 ppm) of the 
spectrum. The Lorentzian Difference Analysis (LDA) can be performed to analyze 
CEST effects. The LDA for uncorrected and baseline corrected CEST spectra is 
shown in figure 6.6D. After subtracting the raw data from the fitted Lorentzian, the 
baseline corrected CEST spectra yields a clean baseline. 
 
6.5.2. Phantom Study 





Figure 6.7. Lorentzian Difference Analysis (LDA) of the different pH phantoms. In 
this figure, APEX is defined as amine proton exchange, which is the average of the 
LDA at (ω=+2.5, +2.6, +2.7, +2.8, and +2.9 ppm), and NOE is defined as the Nuclear 
Overhauser Effects, which is the average of the LDA at (ω=-2.9, -2.8, -2.7, -2.6, and -
2.5 ppm). 
The Lorentzian Difference Analysis gives us a clear distinction of 
exchangeable protons in BSA. Two main peaks are seen: one from amines and 
amides (downfield from water) and one from Nuclear Overhauser Effects (NOE) 
(upfield from water). Additionally, a correlation plot was made to verify that the 
steady state pulsed CEST sequence was indeed sensitive to differences in pH. Figure 









Figure 6.8. Correlation Graph of pH versus Lorentzian Difference (A) at Δω=±2.9 
ppm; and (B) at Δω=±3.5 ppm. 
Figure 6.8A shows that amine protons, which resonate 2.9 ppm downfield 
from water, show a strong negative pH dependence, which is expected based on 
current literature (24) yet NOEs show a strong positive pH dependence. In figure 
6.8B, amide protons show a weaker positive pH dependence yet NOEs still show a 
strong positive pH dependence. This is important because traditionally analysis of 
CEST spectra was performed using MTRasymmetry. However, if there is pH dependence 
in both the 𝑆𝑠𝑎𝑡(−∆𝜔)  and 𝑆𝑠𝑎𝑡(∆𝜔)  terms, then care should be taken when 
interpreting the combination of these images. 
 
6.5.3. Controls 
 Data from all controls did not have hyperintensities in mean diffusion 
weighted images and FLAIR images (in other words, control data was diffusion and 
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FLAIR negative). Figures 6.9 and 6.10 present results from two of the controls over 
six slices that cover the whole brain. pH-weighted images (MTRasymmetry(3.5 ppm), 
APT, and NOE) also show symmetry between the right and left hemispheres and in 
both datasets. 
 
Figure 6.9. Data acquired on a healthy control subject. Select slices from the (A) 
FLAIR scan, (B) Mean Diffusion Weighted Image, (C) MTRasymmetry(3.5 ppm) 
processed from the Steady State Pulsed CEST (pH-weighted), (D) APT processed 
from the Steady State Pulsed CEST scan, and (E) NOE processed from the Steady 




Figure 6.10. Data acquired on another healthy control subject. Select slices from the  
(A) FLAIR scan, (B) Mean Diffusion Weighted Image, (C) MTRasymmetry(3.5 ppm) 
processed from the Steady State Pulsed CEST (pH-weighted), (D) APT processed 
from the Steady State Pulsed CEST scan, and (E) NOE processed from the Steady 
State Pulsed CEST scan. 
  
6.5.4. Patient 1 
Figure 6.11 shows data for an 84 year old female imaged 62 hours after 
symptoms onset, presented with several diffusion positive regions (Figure 6.11A) and 
a perfusion deficit covering the entire vascular territory of the right anterior cerebral 
artery (Figure 6.11B) in the acute scan. This can be seen by an increase in the time to 
peak of the patient’s right hemisphere (left in image; radiological convention). In 
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figure 6.12, a healthy control’s MTRasymmetry(+3.5 ppm) image (Figure 6.12A) is 
compared to the patient’s MTRasymmetry(+3.5 ppm) image (Figure 6.12B) over a 
similar region of interest. Notice that the healthy control’s MTRasymmetry(+3.5 ppm) 
image is symmetric between the two hemispheres whereas the ischemic patient’s 
MTRasymmetry(+3.5 ppm) image is asymmetric because of possible tissue acidosis in 
the right hemisphere. 
 
Figure 6.11. (A) Diffusion weighted scan (mean diffusion weighted image) and  






Figure 6.12. MTRasymmetry (+3.5 ppm) image of (A) healthy volunteer and  
(B) ischemic stroke patient. 
In figure 6.13, two different thresholds for the pH weighted images from 
patient 1 are used (Figure 6.13A: MTRasymmetry (+3.5 ppm) ≤ -3 and figure 6.13B:  
MTRasymmetry (+3.5 ppm) ≤ -2) to determine the pH penumbra. Notice that the pH 
penumbra is contained around the diffusion lesions. Additionally, the PWI penumbra 





Figure 6.13. Images of diffusion lesion (red), possible pH penumbra (blue), and 
perfusion penumbra (green) overlaid on CEST M0 image. Top row: pH penumbra 
was determined with MTRasymmetry(+3.5 ppm) ≤ -3. Bottom row: pH penumbra was 
determined with MTRasymmetry (+3.5 ppm) ≤ -2. 
 Unfortunately, this patient did not receive a follow-up FLAIR scan so we 
could not correlate whether or not the region found to have reduced pH progressed to 
infarction.  
 
6.5.5. Patient 2  
 This patient presented with right middle cerebral artery (MCA) infarct and 
right carotid artery occlusion. Figures 6.14 and 6.15 display this patient’s acute 
FLAIR scan (figure 6.14A&6.15A), acute mean diffusion weighted scan (figure 
6.14B&6.15B), time to peak image (figure 6.14C&6.15C), MTRasymmetry(3.5 ppm) 
(figure 6.14D&6.15D), APT (figure 6.14E&6.15E), NOE (figure 6.14F&6.15F) and 






Figure 6.14. Slices 18 to 23 for Patient 1. (A) Acute FLAIR scan. (B) Acute mean 
diffusion weighted image. (C) Time-to-peak image. (D) MTRasymmetry(3.5 ppm). (E) 




Figure 6.15. Slices 24 to 29 for Patient 2. (A) Acute FLAIR scan. (B) Acute mean 
diffusion weighted image. (C) Time-to-peak image. (D) MTRasymmetry(3.5 ppm). (E) 
APT. (F) NOE (G) Follow-up FLAIR. 
 Notice in the acute FLAIR scan, the hyperintensity is evidence that tissue T2 
has already begun to change in the hyperintense region of the mean diffusion 
weighted image. However, the time to peak image shows an asymmetry in cerebral 
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perfusion between the two hemispheres. Furthermore, the hyperintense region in the 
time to peak image is significantly larger than the diffusion lesion (a diffusion-
perfusion mismatch), which would imply that there is a large region of tissue at risk 
of infarction. However, when analyzing the pH-weighted images (MTRasymmetry(3.5 
ppm), APT, and NOE), the two hemispheres appear symmetric implying that the 
hyperintense region in the time to peak is benign oligemia. This is confirmed in the 
follow-up FLAIR images where final infarct region is limited to the original lesion on 
the diffusion–weighted image. 
 
6.5.6. Patient 3  
 This patient (57 year old male) presented with aphasia and right side weakness. 
Acute MRI confirmed a previous stroke in the right hemisphere and acute infarcts in 
the left watershed distribution region followed with a much larger region of reduced 
perfusion at risk of infarction. We were interested in understanding whether or not 
this patient’s perfusion deficit would progress to infarction so the patient was scanned 
using the acute stroke MRI protocol with pH-weighted imaging. This patient received 
a scan 24 hours after being admitted. However, this patient was uncooperative and 
moved around a lot during the initial scan. He was taken out of the scanner and 
scanned seven days later. An example of the motion is shown in figure 6.16 on the 
DTI scan. Figures 6.17-6.19 detail the results of the scans performed seven days after 





Figure 6.16. Example of patient motion on DTI scan. This image contains a single 
slice of the DTI scan. The 33 images are from the different gradient directions that 
were acquired. The B0 image was left off of this image so signal intensity scaling 




Figure 6.17. Processed data for carotid artery stenosis patient (Slices 16-20) 
(displayed in radiologic convention). (A) Acute FLAIR scan (B) Acute Mean 
Diffusion Weighted scan (C) Acute Time to Peak scan (D) MTRasymmetry(3.5 ppm) 




Figure 6.18. Processed data for carotid artery stenosis patient (Slices 21-25) 
(displayed in radiologic convention). (A) Acute FLAIR scan (B) Acute Mean 
Diffusion Weighted scan (C) Acute Time to Peak scan (D) MTRasymmetry(3.5 ppm) 






Figure 6.19. Processed data for carotid artery stenosis patient (Slices 26-30) 
(displayed in radiologic convention). (A) Acute FLAIR scan (B) Acute Mean 
Diffusion Weighted scan (C) Acute Time to Peak scan (D) MTRasymmetry(3.5 ppm) 
(pH-weighted) (E) APT (F) NOE 
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 The patient’s old stroke in the right parietal-occipital region can be seen in the 
FLAIR scan between slices 18-28. Mean diffusion weighted images show 
hyperintensities between slices 18-29 in the left hemisphere, and time to peak images 
show a large region at risk of infarction covering the entire MCA distribution on the 
left hemisphere. MTRasymmetry(3.5 ppm) images shows regions of possible reductions 
in pH. These regions appear to be smaller in size than the perfusion deficit, which 
may indicate that not all tissue that is indicated to be hypoperfused by the time to 
peak image is at risk of infarction.    
 
6.6. Conclusion 
We present an initial application of using pulsed CEST to image different pHs in 10% 
BSA pH phantoms and translated this to healthy volunteers and eventually to acute ischemic 
stroke patients. Comparison of MTRasymmetry(+3.5 ppm) images between a healthy volunteer 
and an ischemic stroke patient showed a reduction in the MTRasymmetry(+3.5 ppm) in the 
region of delayed perfusion that was attributed to tissue acidosis, and comparison of the pH 
penumbra to the PWI penumbra (by using different TTP delay thresholds) shows that the pH 
penumbra localizes a region smaller than the PWI penumbra. Therefore, APT MRI shows 
sensitivity to pH changes that are not visible using diffusion or perfusion imaging. A patient 
with a large perfusion penumbra that was believed to be benign oligemia was also imaged. 
pH-weighted imaging (MTRasymmetry(+3.5 ppm)) showed symmetric hemispheres similar to 
what was seen for normal volunteers. Follow-up FLAIR imaging confirmed that the large 
perfusion penumbra was indeed benign oligemia as infarction was confined to regions of 
diffusion hyperintensities. And finally, pulsed CEST was applied to a patient with a stenosed 
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Chapter 7: Using CEST and Frequency-Labeled Exchange Transfer 
(FLEX) MRI to Image Blood Oxygenation Dependent Exchangeable 
Protons in Blood (boldCEST/boldFLEX) 
 
7.1. Abstract 
  Blood oxygenation is an important pathophysiological parameter that changes in 
numerous pathological states including ischemia. Previously mentioned in Chapter 1, 
hemoglobin is the protein responsible for binding oxygen in the lungs where there is a high 
partial pressure of oxygen (it becomes oxyhemoglobin here) and for transporting oxygen to 
various parts of the body where oxygen diffuses out of the blood stream (because of a low 
partial pressure of oxygen in tissue) to engage in metabolic processes. Over the past decades, 
high resolution NMR has been used to identify a number of exchangeable proton resonances 
on hemoglobin, some of which have a frequency dependence on oxygenation. Until recently, 
the only way to measure these exchangeable protons was through spectroscopy, which 
offered good specificity, but poor sensitivity. Recently, chemical exchange saturation transfer 
MRI has been proposed as a novel way of increasing sensitivity of MR to exchangeable 
protons. And even more recently, a more powerful technique, frequency labeled exchange 
transfer (dubbed FLEX) MRI, not only increases sensitivity to exchangeable protons but can 
also measure multiple protons simultaneously and quantify exchange rates. In this chapter, 
we aim to use chemical exchange saturation transfer and frequency-labeled exchange transfer 





Oxygenation is an important pathophysiological parameter that changes in many 
pathological states such as ischemia and chronic obstructive pulmonary disease. Oxygenation 
can be imaged using positron emission tomography (PET) and magnetic resonance imaging 
(MRI). PET imaging of oxygenation involves injecting a radiotracer into the body and 
tracking the tracer as it decays. On the other hand, MRI is capable of imaging oxygenation 
non-invasively with non-ionizing radiation, which makes it the ideal modality of imaging 
when tracking the course of a heterogeneous disease such as acute ischemic stroke. 
Currently, magnetic resonance techniques that are sensitive to blood oxygenation 
include blood oxygenation level dependent (BOLD) functional magnetic resonance imaging 
(BOLD fMRI), T2 relaxation under spin tagging (TRUST), global oxygen extraction fraction 
(OEF) measurement at internal jugular vein, Gradient Echo Sampling of Spin Echo (GESSE), 
and quantitative imaging of extraction of oxygen and tissue consumption (QUIXOTIC) (1-5). 
BOLD fMRI uses a gradient echo sampling scheme with an echo time of approximately 25 
ms at 3 Tesla to be sensitive to decreases in paramagnetic deoxyhemoglobin between a 
resting state and activated state (where a subject is asked to perform a certain task). Theory 
has been developed to show that these decreases in paramagnetic deoxyhemoglobin arises 
from increased cerebral blood flow (CBF), cerebral blood volume (CBV), and oxygen 
extraction fraction (6). TRUST MRI and the global OEF measurement at the internal jugular 
vein measures the transverse relaxation time (T2) of venous blood and uses a calibration 
curve to map the T2 to the oxygen extraction fraction (OEF). Issues with these methods are 
that they are not spatially resolved and only give whole brain oxygenation values. GESSE 
(otherwise known as quantitative BOLD) uses a gradient echo sampling scheme to sample 
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magnetization around a spin echo and uses susceptibility theory to data to parameters OEF, 
deoxygenated blood volume, ratio of interstitial fluid and cerebrospinal fluid, R2 (inverse of 
transverse relaxation time, T2) of brain tissue, frequency shift, and brain concentration of 
deoxyhemoglobin. One issue with the GESSE technique is its high number of fitting 
variables, which can lead to high degrees of freedom where multiple solutions are possible. 
And finally, QUIXOTIC uses velocity selective modules (RF pulses and associated gradients) 
to define a bolus of blood leaving the capillaries and then label this bolus in a similar manner 
as arterial spin labeling described earlier in Chapter 4. The labeled bolus is then subtracted 
from a control bolus defined similarly. Because velocity selective modules can be spatially 
resolved, QUIXOTIC offers spatially resolved information about oxygenation in the brain. 
However, it suffers from low signal-to-noise ratios.  
One method that has not been exploited to image oxygenation in the body is by using 
exchangeable proton signals in blood, which is responsible for delivering oxygen throughout 
the body so organs can produce energy and function and transporting waste products to be 
disposed of. Blood has four main constituents: erythryocytes, plasma, leukocytes, and 
thrombocytes. Hemoglobin, found in erythrocytes, is the protein in the body responsible for 
the transport of oxygen. It is a large molecule (65 kiloDalton) composed of two α strands 
(each with 144 amino acids) and two β strands (each with 146 amino acids) and has many 
exchangeable protons on it that have been studied in detail by many groups using nuclear 
magnetic resonance (NMR) (7-14). A good review that summarizes much of the work that 
has been done on exchangeable protons in oxyhemoglobin, deoxyhemoglobin, and 
carbonmonoxy-hemoglobin using NMR between the 1970s and 1980s was written by Drs. 
Chien Ho and Dr. Janice Perussi in 1994 published in Methods in Enzymology (15).  
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Recently, chemical exchange saturation transfer (CEST) MRI has been introduced to 
provide amplification of micromolar concentrations of exchangeable protons (16, 17). CEST 
MRI does this by capitalizing on the chemical exchange trait of certain protons (OH, NH) in 
molecules. CEST uses a saturation pulse to irradiate protons resonating at a particular 
frequency, which makes them “invisible” to MR detection. If enough of the irradiated 
protons exchange with bulk water, then the ultimate effect will be a reduction in the detected 
water signal. By utilizing the exchange with bulk water, CEST is a powerful technique with 
the capability of amplifying millimolar concentrations of compounds to be detected with the 
molar water signal of MRI. CEST has been demonstrated to be sensitive to changes in pH, 
protein content, and temperature and has been applied in the clinic to study brain tumors and 
acute stroke (18-21). CEST MRI has also been used to study exchangeable protons in the 
serine protease system (22). However, CEST MRI has not yet been used to study 
exchangeable protons on hemoglobin, which has a high intracellular concentration (~5 mM) 
in erythrocytes and a sufficiently large number of exchangeable protons to make it a suitable 
target for applying CEST MR imaging to.  
Frequency-labeled exchange (FLEX) transfer MRI is a novel imaging technique that 
has recently been shown to be sensitive to slowly and quickly exchanging protons (23-25). 
FLEX MRI modulates the water intensity by encoding the chemical shift of exchangeable 
proton groups through label transfer modules (LTMs), which consist of four parts: 1) a 
selective 90𝑥°  pulse that excites protons over a large range of frequencies and minimizes 
excitation of water; 2) a delay during which excited protons undergo chemical shift evolution; 
3) a selective 90−𝑥° pulse that flips the magnetization back to the longitudinal axis; and 4) 
another delay for labeled protons to exchange into the bulk water pool. Sensitivity 
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enhancement for low concentrations of exchangeable protons can be achieved by increasing 
the number of LTMs. Because of the flexibility of the FLEX sequence (can be tuned to detect 
slowly or quickly exchanging protons, RF pulse placed closer to water can detect 
exchangeable resonances close to water or further away can detect exchangeable proton 
resonances over a larger range), we applied FLEX MRI to image blood to look for 
exchangeable proton resonances in blood. 
In this chapter, we aim to use CEST and FLEX MRI to try to detect blood 
oxygenation dependent exchangeable protons in bovine blood. 
 
7.3. Materials  
In this chapter, two types of hemoglobin were investigated: adult human hemoglobin 
bound to carbon monoxide and bovine hemoglobin. In the next section (Section 7.4.1), we 
will describe why the use of bovine blood is more advantageous than human blood for this 
particular project. 
 
7.3.1. Sample: Why Bovine Blood? 
Bovine blood was used as the main model system for this study. Bovine blood 
has similar characteristics as human blood (14). One advantage for using bovine 
blood over human blood in this is that human blood contains 2,3-diphosphoglycerate 
(2,3-DPG), which is used for control of oxygenation. However, when human blood is 
removed from the body, the concentration of 2,3-DPG becomes depleted very quickly, 




7.3.2. Carbonmonoxy Hemoglobin 
Because of carbon monoxide’s high binding constant to hemoglobin (250x 
that of oxygen), carbonmonoxy hemoglobin is an ideal sample to use when 
developing and optimizing pulse sequences. Hemoglobin can be purified, dissolved in 
PBS, ligated to carbon monoxide, and stored away in a sealed glass tube for an 
extended period of time. Additionally, it serves as a good control for exchangeable 
protons of oxyhemoglobin and deoxyhemoglobin because of conformational 
differences between these three structures (15). This results in different chemical 
shifts for each of exchangeable protons on each protein.  
Human adult blood samples were obtained from a local blood bank. Human 
adult hemoglobin (Hb A) was isolated and purified by established methods in Dr. 
Chien Ho’s laboratory (15). All Hb A samples used were in the CO-ligated form in 
0.1 M sodium phosphate buffer at pH 7.4, and the Hb A concentrations (in terms of 
tetramer) used in this study were about 2.4 mM and 4.9 mM. 
 
7.3.3. Whole Blood  
Fresh bovine blood was provided by a local slaughterhouse. The blood was 
collected into a container filled with a distilled de-ionized water solution of the 
anticoagulant sodium citrate to give a final concentration of 25 mM. Blood was 
filtered to remove clots and impurities accumulated during the procedure of blood 
collection. 
Whole blood samples of 44% hematocrit were prepared by spinning down 
whole blood using a centrifuge (Beckman Coulter Avanti Centrifuge J-25I, Rotor 
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Number: JA-10) at 10,000 G for 15 minutes. Plasma and packed erythrocytes were 
combined and mixed to create a sample with 44% hematocrit. Oxygenation of the 
44% hematocrit sample was manipulated by using a gas tank (Airgas) filled with 94% 
nitrogen, 5% oxygen, and 1% carbon dioxide. pH of the sample was manipulated by 
using a gas tank (Airgas) filled with 100% carbon dioxide. Hematocrit, pH and 
methemoglobin (MetHb) values, together with the blood oximetry parameters sO2, 
pO2 and pCO2 were measured with a blood gas analyzer (Radiometer ABL 700 series, 
Radiometer, Copenhagen, Denmark). All blood samples were stored at 4°C and used 
within a week after preparation. During that time, none of the samples exhibited any 
formation of blood clots or increase in MetHb levels. 
 
7.3.4. Washed Erythrocytes 
Because whole blood is largely constituted of plasma and erythrocytes, it is 
possible that detected signals using whole blood could come from proteins in plasma. 
Therefore, it is important to verify that detected exchangeable proton signals are 
indeed coming from hemoglobin. One way of doing this is to wash whole blood using 
phosphate buffer solution. The resulting sample would have no plasma with 
erythrocytes suspended in buffer solution. 
Washed erythrocytes were prepared by centrifuging (Beckman Coulter Avanti 
Centrifuge J-25I, Rotor Number: JA-10) whole blood at 10,000 G for 15 minutes, 
extracting plasma, and replacing immediately with phosphate buffer solution (PBS). 
The solution was hand mixed for 10 minutes to ensure adequate mixing between 
packed erythrocytes and PBS and centrifuged again at 10,000 G for 15 minutes. PBS 
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was extracted and replaced immediately with new PBS. This solution was mixed for 
30 minutes to ensure adequate mixing between packed erythrocytes and PBS. This 
mixture was centrifuged at 10,000 G for 15 minutes, and PBS was extracted and 
replaced with new PBS to give a solution of 44% hematocrit washed erythrocytes. 
The first time we performed the procedure, we put a smear of cells under a 
microscope (Olympus, IX71) at 40x magnification to verify that erythrocytes 
maintained their shape after washing (figure 8.1). 
 
Figure 7.1. Washed Cells Under a Microscope at 40x Magnification. 
It can be seen that the washing process did not perturb the isotonicity of 
erythrocytes. This is important as we want to study erythrocytes in their normal 





7.3.5. Experimental Set-up 
Blood was circulated in a gas exchange perfusion system at a controlled 
physiological temperature (37 °C) within the 700 MHz spectrometer. Details of the 
perfusion system setup were described previously (15). Blood was sampled right 
before and after the MR measurements and oxygenation determined using a blood gas 
analyzer (Radiometer, ABL700) to ensure less than 2% difference of oxygenation. 
Additionally, blood pO2 was monitored during the MR measurement with a needle-
encased sensor (Oxford Optronix, Oxford, UK) placed close to the spectrometer. 
 
7.3.6. Flow Analysis 
There are two reasons why we flowed blood through a perfusion system for 
these measurements: (1) CEST experiments require sweeping over a wide range of 
frequencies and can take up to an hour and sometimes more (more details on this 
later). Erythrocyte sedimentation rates (as a measure of how quickly erythrocytes 
settle in a test tube in 1 hour) of normal blood are in the range of 10-30 mm/hr (26). 
Without flow, erythrocytes would quickly settle to the bottom of a sample tube and 
the distribution of erythrocytes and plasma would be uneven (erythrocytes as the 
bottom and plasma on top). (2) Blood is constantly flowing through the body. Any 
technique developed for the measurement of oxygenation should take this into 
account. However, both CEST and FLEX MRI have several seconds of “labeling” 
where radiofrequency pulses are used to “label” exchangeable spins in the blood. If 
flow is turned on during labeling periods, we need to be sure that the sample that is 
being “labeled” does not flow out of the detection coil before it is being imaged. 
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Therefore, we performed a quick analysis to determine the optimal flow speeds for 
this experiment.  
To experimentally determine the flow speed of the motor (which has 3 
settings: 1-3), we pumped phosphate buffer throughout the tubing, dripped it into a 14 
mL Falcon tube, and timed how long it took (at three different flow settings) for the 
14 mL Falcon tube to be immersed with buffer. Table 7.1 displays the results of the 
flow speed tests.  
  
Table 7.1. Data from Flow Speed Tests  
Flow 
Setting 
Try 1 (s) Try 2 (s) Try 3 (s) Summary (s) Calculated 
Flow Speed 
1 82 86 85 84±2 0.17 mL/s 
2 45 45 45 45±0 0.31 mL/s 
3 28 30 29 29±1 0.48 mL/s 
 
In order to calculate how long we should label, we need to calculate the 
volume of blood that is labeled with the RF coil. To derive this number, we can use 
the volume of a cylinder equation:  
𝑉 = 𝜋 ∗ 𝑟𝑎𝑑𝑖𝑢𝑠2 ∗ 𝐿𝑒𝑛𝑔𝑡ℎ = 3.14 ∗ (0.5 𝑐𝑚)2 ∗ 3 𝑐𝑚 = 2.36 𝑐𝑚3  (Equation 7.1) 
Then the percentage of label flown out can be calculated by multiplying the 





Table 7.2. Percentage of Label Flown at for Different Flow Speeds 
Flow Setting 
and (Speed) 
1 s label 2 s label 3 s label 4 s label 5 s label 
1 (0.17 mL/s) 7.1% 14% 21% 28% 35% 
2 (0.31 mL/s) 13% 26 % 40% 53% 66% 
3 (0.48 mL/s) 20% 41% 61% 82% 102% 
 
It can be seen that with a five second label duration at a flow speed of 3 (0.48 
mL/s), all of the label will have flowed out. Therefore, a five second CEST labeling 
duration at a flow speed of 3 would only waste time. Thus, we decided to try CEST 
labeling durations of one, two, and three seconds. More details about this will be 
described later. 
 
7.4. Methods – Part 1 
All MR experiments were carried out on a 700 MHz (16.4 T) Bruker Avance 
Spectrometer (Billerica, MA) equipped with a 1000 W amplifier and a 30 mm 
imaging transceiver coil connected through a 300 W combiner for dual channel 
quadrature detection. 
 
7.4.1. Optimizing Spin Echo 
When choosing an acquisition method for a sequence, it is important to 
consider speed (gradient echo is a faster sequence that will allow shorter echo times 
to be used, resulting in higher signal to noise if samples have a short T2) and signal-
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to-noise (spin echo has a higher signal to noise because of ability to refocus 
inhomogeneities caused by paramagnetic species, such as the deoxyhemoglobin we 
plan on imaging). In CEST imaging, exchangeable protons yield signals that depend 
on a number of different factors such as concentration, exchange rate, saturation pulse 
B1, and saturation pulse duration. However, because these signals are typically on the 
order of a few percent, imaging sequences with high signal-to-noise are especially 
important and we therefore chose to use a spin echo acquisition scheme.  
When imaging, it is important to excite a homogeneous slab of signal to image. 
To do this, we can use slice selection gradients with the 90° and 180° pulse and use a 
read-out gradient to create a 1-dimensional profile of the sample (shown in figure 7.2).  
 
Figure 7.2. 1D Profile Read-out of Spin Echo. Slice thickness = 3 cm. 
 
7.4.2. FLEX Imaging Parameters 
In our initial proof-of-principle scan, we wanted to sweep a wide range of 
frequencies and detect all possible exchangeable protons in the whole blood. To do 
this, we wanted to place the FLEX pulse as far away from the water frequency as 
possible. The calculation of the FLEX pulse offset is derived from the off-resonance 
field generated by hard pulses (Δωeff): 
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∆𝜔𝑒𝑓𝑓 = �𝜔12 + ∆𝜔𝑠012          (Equation 7.2) 
Where is the ω1 is the B1 field strength, and Δωo1 is the offset frequency. An 
offset ∆𝜔𝑠01 can be chosen such that the product 𝜔𝑒𝑓𝑓 ∙ 𝜏90 is 2π radians on water and 
π/2 for exchangeable protons to minimize water excitation thereby functioning as a 
water suppression pulse. This relationship is then governed by equation 7.3.   
∆𝜔𝑠𝑜1 = 𝜔1 ∙ √15        (Equation 7.3) 
Using the highest power we could (limited only by hardware), we determined 
that we could use a 30 µs pulse placed at 32266.67 Hz (or +46.10 ppm at 700 MHz). 
However, this offset is actually a little bit unfortunate because we were originally also 
interested in imaging the histidine proton (known as the distal histidine) next to the 
iron on deoxyhemoglobin. Previous research has shown that the chemical shift of the 
distal histidines of the alpha and beta globin chains in this deoxygenated molecule are 
at 58.5 ppm and 71.0 ppm, respectively (27).  
Other FLEX parameters that need to be defined include: 1) the evolution time 
and number of tevolution times needed to encode the chemical shift evolution of 
exchangeable proton peaks; 2) the exchange time, which is the delay after labeling 
used for labeled peaks to exchange to bulk water (this exchange time parameter can 
also be tuned for the FLEX sequence to be sensitized to slowly or quickly exchanging 
protons); and 3) the number of LTMs, which is the number of repetitions of the label 





Figure 7.3. FLEX Sequence. RF pulses are represented using blue blocks: The FLEX 
90° and -90° pulses were block pulses; and the 90° and 180° pulses for spin echo 
were Gaussian pulses. Gradients are represented in yellow. A gradient was used 
during the texch period to dephase any residual transverse magnetization. The next two 
gradients are for slice selection for the 90° pulse. This is followed by a dephase 
gradient, slice selection gradient for the 180° pulse, and readout gradient. 
In our initial efforts, we chose to vary the evolution times between 0 and 1 ms 
in increments of 5 µs (also known as the dwell time). The duration of the dwell time 
is important in fulfilling the Nyquist sampling theorem, which defines the minimum 
sampling rate to be twice the frequency of the signal of interest. Using a 5 µs dwell 
time applied at a reference frequency of 32,266.67 Hz, we would be able to 
adequately measure signals oscillating at 100,000 Hz away from our reference 
frequency. We decided to initially go with 400 LTMs with a single LTM duration of 
5 ms (yielding a texch of 4.94 ms), which gives us a total FLEX preparation time of 
two seconds (400*5 ms = 2000 ms). Using a short exchange time sensitizes the FLEX 
sequence to fast exchanging protons because after the protons are frequency labeled, 
they are only given a short period of time to exchange with bulk water. Therefore, the 
label on fast exchanging protons is transferred effectively whereas the label on the 
more slowly exchanging protons does not have enough time to exchange yet. The 
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reason why our initial efforts focused on fast exchanging protons is because the 
protons that we were interested in detecting are histidine protons, and past research 
has shown that histidine protons can exchange between 500-10,000 times per second 
(28). 
Multi-pulse sequences such as the FLEX may have contamination from many 
signal components, for instance stimulated echoes. An important way to improve the 
signal quality of FLEX experiments is through phase cycling, which can be used to 
eliminate unwanted signals from NMR experiments on the basis of their phase. In 
order to get phase-sensitive spectra, we acquired a cosine and sine component for the 
FLEX signal. Phase cycling for the cosine component employed 0°, 90°, 180°, 360° 
with the flip-back pulse set to 180°, 270°, 0°, 90°. Phase cycling for the sine 
component was implemented with 0°, 90°, 180°, 270° with the flip-back pulse set to 
90°, 180°, 270°, 0°. To make sure phase cycling does not adversely affect our spectra, 
we ran FLEX experiments with the following parameters on the 4.9 mM HbCO 
sample:  
Experiment 1) tevol = 0 to 1 ms (increment 5 µs), texch = 10 ms, LTMs = 400, without 
phase cycling. 
Experiment 2) tevol = 0 to 1 ms (increment 5 µs), texch = 10 ms, LTMs = 400, with 
phase cycling. 
Experiment 3) tevol = 0 to 1 ms (increment 5 µs), texch = 20 ms, LTMs = 400, without 
phase cycling. 




Results of these four experiments are presented below in figure 7.4.  
 
Figure 7.4. (A) FLEX, texch = 10 ms, without phase cycle (B) FLEX, texch = 10 ms, 
with phase cycle (C) FLEX, texch = 20 ms, with phase cycle (D) FLEX, texch = 20 ms, 
without phase cycle 
Based on the data presented in figure 7.4, phase cycling appears to help clean-
up unwanted signals in our FLEX acquisition and does not appear to introduce any 
unwanted artifacts.  
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Additionally, it is important to check FLEX excitation profiles to verify that 1) 
water excitation is minimized; and 2) the range of exchangeable protons that we are 
interested is properly excited. FLEX excitation profiles were acquired experimentally 
on a sample of 44% hematocrit 100% oxygenated whole blood by applying a 90° 
pulse across a wide range of offset frequencies. Excitation profiles for FLEX pulse 





Figure 7.5. FLEX Excitation Profiles for (A) 30 µs block pulse applied at +46.10 ppm  
(B) 40 µs block pulse applied at +34.57 ppm  
It appears that there may be some overtipping of the FLEX excitation pulses 
near the frequency offset where the pulse is applied, but the excitation profiles follow 
what we would expect for these pulses.  
 
7.4.3. CEST Imaging Parameters 
The CEST sequence is composed of three main parts: 1) Pre-scan delay, to 
allow for enough time for the magnetization to recover after saturation; 2) Saturation 
Pulse, to saturate over a range of frequencies so saturated exchangeable protons can 
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exchange into bulk water and replaced by non-saturated protons; and 3) Acquisition. 
The optimized CEST sequence is displayed in figure 7.6.  
 
Figure 7.6. CEST Sequence. RF pulses are represented in blue: the saturation pulse is 
represented by a blue box because a block pulse was used for it; and Gaussian pulses 
were used for spin echo 90° and 180°. Gradients are represented in yellow. The 
gradient after the CEST pulse is to dephase any transverse magnetization left after the 
CEST pulse. The next two gradients are for slice selection for the 90° pulse. This is 
followed by a dephase gradient, slice selection gradient for the 180° pulse, and 
readout gradient.   
An unsaturated CEST scan (S0) was collected after all of the saturated 
volumes were collected and was composed of exactly the same sequence but with the 
B1 of the saturation pulse set to zero.  
 
7.4.4. Optimizing CEST Saturation Pulse Duration 
One important parameter to optimize in CEST experiments is the saturation 
pulse duration. A quick glance at how the saturation efficiency of the CEST pulse is 
determined (equations 7.3-7.5) would tell us that a saturation pulse of infinite 






         (Equation 7.3) 
𝑝 = 𝑟2𝑐 −
𝐶𝑎𝑐𝐶𝑐𝑎
𝑟2𝑎
        (Equation 7.4) 
𝑞 = 𝑟1𝑐 −
𝐶𝑎𝑐𝐶𝑐𝑎
𝑟1𝑎
        (Equation 8.5) 
Where r1c is the sum of R1c, the longitudinal relaxivity of the amide proton 
and Cac, the exchange rate between bulk water and the amide proton and r2c is the sum 
of R2c, the transverse relaxivity (inverse of T2c) of the amide proton and Cac, the 
exchange rate between bulk water and the amide proton. Additionally, it can be 
simulated that exchangeable proton pools with a short T2 do not undergo complete 
saturation with short saturation pulses.  
At 37°C bovine blood is only fresh for a certain period of time (~12 hours), so 
we want a short enough saturation pulse to minimize scan time yet a long enough 
saturation pulse to increase the CEST effect (PTR) and minimize artifacts from the 
possibly short T2 of exchangeable protons on hemoglobin. At low oxygenation (60%) 
and high field (700 MHz), T2 of deoxygenated blood is very short (~13 ms for 44% 
hematocrit and τcpmg = 0.5 ms (unpublished data)). We put in a sample of 44% 
hematocrit whole blood at 65% oxygenation and ran three CEST experiments with B1 
= 14.1 µT but with different saturation times (1 seconds, 2 seconds, 3 seconds) with 
the pre-scan delay set to 8 seconds over the frequency range -5 ppm to 5 ppm in 




 Figure 7.7. Data Over Multiple Saturation Pulse Durations. 
“Wiggles” (green boxes) in the CEST spectra show that a saturation pulse 
duration of less than three seconds may not be long enough for the exchangeable 
protons in blood to be in steady state saturation. Based on this data, we chose a 
saturation pulse duration of three seconds for our CEST experiments. Now that we 
have determined the saturation pulse duration, we can estimate a pre-scan delay 
needed to allow magnetization to return back to normal. It is well-known that five 
times the longitudinal magnetization relaxation time is enough time for magnetization 
to recover. We ran a quick inversion recovery experiment and quantified the T1 of 
44% hematocrit, 100% oxygenated blood to be 2,462 ms. Five times of that would be 
12.31 seconds. Interestingly, because the blood is constantly flowing, another way to 
calculate a pre-scan delay would be to figure out how long it takes for the current 
bolus to flow out. To do this, we could divide the volume of blood that the coil 
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excites (2.356 mL) by the flow speed (0.49 mL/second) and arrive at 4.8 seconds. We 
could even add one second for a margin of error. After six seconds, the bolus of blood 
that was previously saturated has already flowed out. Therefore, we selected a pre-
scan delay of six seconds. 
Another parameter that needs to be chosen for CEST experiments is the 
saturation pulse B1. The simplified solution for saturation efficiency (α) under slow 
exchange conditions on the NMR time scale tells us that the B1 we choose for our 




        (Equation 7.6) 
Where γ is the gyromagnetic ratio of hydrogen (267.53x106 𝑟𝑎𝑑
𝑠∙𝑇
), B1 is the 
power of the saturation pulse, and ksw is the exchange rate of the exchangeable proton. 
Because the histidine protons that we were trying to detect has a fast exchange rate, 
we chose to use a 14.1 µT pulse.  
And finally, the last CEST parameter that needs to be set is the frequency 
range over which the saturation pulse will be swept. Previously, we mentioned in the 
FLEX section that it may also be interesting to detect the distal histidine of 
deoxyhemoglobin. However, in order to detect that far away from water, it would be 
necessary to sweep from +80 ppm to -10 ppm in order to capture the water offset to 
determine whether or not there was a B0 shift over the period of our experiment. 
However, in order to have enough spectral resolution to differentiate narrow peaks, 
we would have to acquire a point every 0.2 ppm, which would make the total scan 
time 67 minutes and 48 seconds long for a single oxygenation and a single B1. To be 
practical, we decided we would use the FLEX scan to “screen” the blood to see if 
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there were any exchangeable proton resonances on deoxyhemoglobin. If so, then we 
would run a CEST scan with frequency offsets from +80 ppm to -10 ppm in 
increments of 0.2 ppm. Otherwise, we would restrict ourselves between +15 ppm to -
15 ppm in increments of 0.2 ppm. 
 
7.4.5. 1-H WATERGATE Imaging Parameters 
 Traditionally, exchangeable protons have been detected using spectroscopic 
sequences with water suppression that does not saturate the water signal until just 
before acquisition of the spectra, such as the well-known WATERGATE (3-9-19) 
sequence (30). Because spectroscopy has been previously used to study exchangeable 
protons on hemoglobin, we believed that it would be an independent check for any 
exchangeable protons detected with CEST or FLEX. However, after optimizing the 
1H-WATERGATE sequence, we checked the excitation profile and realized we could 
only acquire between -10 ppm and 11 ppm if we wanted at least 1% excitation 





Figure 7.8. Excitation Profile of 1H-WATERGATE sequence on 700 MHz scanner.  
 We realized that the reason why this happened was because of hardware 
limitations. Using the highest power we could achieve on the 30 mm imaging probe, 
the shortest duration of the longest rectangular pulse in the 3-9-19 pulse train was 
59.50 µs. In the frequency domain, this would be equal to 16,807 Hz, which at 700 
MHz, corresponds to 24 ppm. This means that the excitation profile of a 
WATERGATE sequence will be a convolution of the WATERGATE excitation 
profile with infinitely short pulses with the frequency response of a 59.5 µs pulse 





Figure 7.9. Explanation of why WATERGATE at 700 MHz using our hardware does 
not work.   
  
7.5. Data Processing 
All data was processed using in-house written MATLAB® R2008a (The Mathworks, 





7.5.1. FLEX Processing 
The FLEX FID was generated by integrating the spin echo projection of the 
sample at each evolution time for both cosine and sine components. Next, the FID 
was normalized by the integral of S0 and multiplied by 100 to yield a percentage. 
Then, we fit the S/S0 cosine and sine FIDs to the five component exponential FLEX 
equation (equation 7.7).  
 𝐹𝐿𝐸𝑋𝐹𝐼𝐷 = ∑ 𝑃𝑇𝑅𝑠 ∙ 𝑒−(𝑘𝑠𝑤+𝑅2
∗)∙𝑡𝑒𝑣𝑜𝑙 ∙ cos(∆𝜔𝑠𝑜1 ∙ 𝑡𝑒𝑣𝑜𝑙 + 𝜑)𝑠   (Equation 7.7) 
Where PTRs is the amplitude of the exchangeable proton resonance, 𝑅2∗  is 
inverse of the time constant of the loss of phase coherence of the exchangeable 
protons, Δωs01 is the frequency difference between the resonance offset of the 
exchangeable proton and the frequency offset of the FLEX excitation pulse. A five 
compartment model was chosen because the first component was fitted for low 
frequency drift, the second component was fitted for the amide proton component, the 
third component was fitted for NOEs, the fourth component was fitted for bulk water, 
and the last component was allowed to vary to fit for the oxygenation dependent peak. 
Fitting bounds for the frequency of the last component were used to prevent other 
peaks from being fitted. After determining the baseline and low frequency drift using 
the fitted values, we subtracted these from the data to derive the baseline-corrected 
FLEX FID. Then, we combined the real (cosine FLEX) and imaginary (sine FLEX) 
components using the Hilbert transform theory to arrive at the combined FID. To 
prevent truncation artifacts that frequently arise from not sampling the FID until the 
signal has completely decayed, we applied a cosine filter over the time domain. 
Finally, we took the Fourier transform of the combined FID to get the phase-sensitive 
153 
 
frequency spectrum. To calculate the frequency offsets for the spectrum, we 
calculated the sweep width to be the inverse of the dwell time, defined as the 
increment in FLEX evolution times. Zeroth order and first order phase corrections 
were performed the same way as Friedman et al (23).  
Additional data processing to study what we believed to be an oxygenation 
dependent peak in the FLEX spectrum included time domain fitting using the 
exponential FLEX equation to fit out the amide proton, water, and Nuclear 
Overhauser Effects from the FID. After subtracting out the amide proton, bulk water, 
and NOEs from the fid, we were left with a spectrum with only a peak at 10 ppm. 
 
7.5.2. CEST Processing 
At each irradiation offset frequency, the raw CEST data were processed by 
applying a Fourier Transform to the spin echo to get the 1D projection of the sample. 
Then, the spin echo was integrated over the frequency spectrum to get a single 
intensity value. This value was then normalized using the first unsaturated (S0) scan 
acquired and multiplied by 100 to yield a percentage value.  
Because of scanner drift, S0 scans were interspersed throughout the data 
acquisition after every ten frequencies. CEST baseline correction was performed on 
the z-spectra similarly to the method described in Chapter 6.  





     (Equation 7.6) 
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 Where Ssat(-Δω) is the saturated volume acquired Δω ppm upfield of water, 
Ssat(Δω) is the saturated volume acquired Δω ppm downfield of water, and S0 is the 
unsaturated image. 
 
7.6. Results & Discussion – Part 1 
7.6.1. Carbonmonoxy Hemoglobin 
The FLEX results for carbonmonoxy hemoglobin are displayed in figure 7.10. 
The results are in line with what is expected for the two concentrations of HbCO. A 
higher concentration of HbCO would yield peaks with higher protein effects (amide 
protons and NOEs). The difference in the water peak arises from the difference 
between the T1 of the two samples. It is also clear that there are no other peaks from 
exchangeable protons in this spectrum, which is also in line with what is understood 
about carbon monoxy hemoglobin.  
 
Figure 7.10. FLEX results for 2.4 mM and 4.9 mM HbCO. 
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The FLEX spectrum for carbonmonoxy hemoglobin at two different 
concentrations both shows three main peaks. The peak downfield of water (to the left 
of water) around +3.5 ppm are amide protons on the carbonmonoxy hemoglobin 
protein. The peak at 0 ppm is the bulk water signal. Notice between the two different 
concentrations of HbCO that the bulk water peak is slightly different. This is because 
the bulk water peak is proportional to T1 and T2, which is probably different between 
these two concentrations. And finally, the peak on the right around -4 ppm is due to 
NOEs. 
The CEST results for 4.9 mM HbCO are shown in figure 7.11 for a saturation 
pulse duration of five seconds with B1 = 1.4 uT. 
  
Figure 7.11. CEST (top) and MTRasymmetry (bottom) spectra for 4.9 mM concentration 
of HbCO.  
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 The CEST spectra of the 4.9 mM HbCO is in line with the results of the 
FLEX data. There is a clear peak from amide protons around 3.5 ppm, and a peak 
between -5 and -2 ppm from NOEs. There do not appear to be any other 
exchangeable protons detectable with CEST or FLEX at this concentration of HbCO. 
 
7.6.2. 30 µs FLEX of 44% Hematocrit Whole Blood  
The initial results of the multi-oxygenation scan were quite interesting and 





Figure 7.12. FLEX Results of Multi-oxygenation Scan (A) FLEX results for 5 
different oxygenations. (B) Amide Proton, Bulk Water, and NOE-filtered FLEX 
spectrum  
(C) Zoomed-in 10 ppm peaks for 5 different oxygenations (D) Linear correlation of 
Oxygenation vs Peak Amplitude, r2 = 0.86 
FLEX scans run on a sample of 44% hematocrit whole blood over a range of 
oxygenations show a possible oxygenation dependent peak around 10 ppm (figure 
7.12A). To further study the peak, bulk water, amide protons, and NOEs were filtered 
out using time domain analysis only to leave the peak around 10 ppm (figure 
7.12B&figure 7.12C). After independently phase correcting each peak, there appears 
to be an oxygenation dependent at 10 ppm. When plotting the peak amplitude against 
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oxygenation (figure 7.12D), there is a strong correlation (r2 = 0.86) with the equation 
relating the two being: 
Peak Amplitude = -0.001*O2+0.236     (Equation 7.7) 
I thought that I imaged the so-called “T-marker” that uniquely identifies 
deoxyhemoglobin, resonating at 9.4 ppm with respect to water (8). It was previously 
identified by Fung et al (8) to be a hydrogen bond between α42 tyrosine and β99 
aspartic acid at the α1β2 interface and follows a similar behavior as what we have 
uncovered. It can be argued that the exchangeable proton that our data points to is 
sitting at 10.3 ppm from water so this is not necessarily the T-marker. However, it is 
widely known that chemical shift is very sensitive to environment and protein 
conformation. In Fung et al’s studies, they isolated human hemoglobin A and 
dissolved it in a phosphate buffer of pH 7.4 whereas we were imaging bovine whole 





7.6.3. 30 µs FLEX of Washed Erythrocytes 
After seeing the previous results, we were worried that the peak may have 
been from proteins (albumin) in plasma. To test our hypothesis that the peak is due to 
an oxygenation dependent exchangeable proton on hemoglobin, we washed the 
erythrocytes to remove plasma and ran the FLEX scan on a sample of 100% 
oxygenated washed erythrocytes and a sample of 65% oxygenated washed 





 Figure 7.13. FLEX data and spectra of 44% hematocrit washed erythrocytes with  
(A) 100% oxygenation; and (B) 65% oxygenation.  
Interestingly, we still saw a peak in the sample with lower oxygenation, and 
the peak appeared inverted in the higher oxygenated sample. Thus, FLEX spectra 
acquired on washed cells confirm the existence of an oxygenation dependent peak 
around 10 ppm and show that this peak is not due to proteins in plasma. In figure 
7.13A, the peak around 10 ppm appeared to be inverted, but at the time, we thought 
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this was something that could be corrected with data processing. More details on this 
later.  
 
 7.6.4. CEST of Whole Blood 
 After showing that the peak at 10 ppm could be due to an exchangeable proton 
on deoxyhemoglobin, we decided to move to CEST imaging. Using the results of the 
FLEX spectra, we thought we were imaging a histidine proton and used a higher 
saturation pulse B1 for CEST imaging because of faster exchange rates of histidine 
protons. The results of imaging 44% hematocrit whole blood at multiple oxygenations 
using CEST is presented in Figure 7.14.  
 
Figure 7.14. CEST spectra (top) and MTRasymmetry (bottom) for 44% hematocrit 
Whole Blood at Multiple Oxygenations. 
 Oddly, we did not see the exchangeable proton we thought we were able to 
image from the FLEX data. However, we do believe that this data makes sense. When 
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looking at the CEST spectra, the direct saturation region becomes wider for lower 
oxygenations. This is due to a shorter T2 in lower oxygenations and is in line with 
what is published in literature.  
 
7.6.5. Varying Offset (and Pulse Duration) for FLEX Imaging on 44% Hematocrit 
Whole Blood at 66% Oxygenation 
Therefore, we decided to go back to FLEX imaging to understand why this 
was happening. Using a 30 µs pulse, one simple modification we can make to the 
pulse sequence is to apply the pulse at -46.10 ppm (instead of +46.10 ppm). If an 
exchangeable proton were to resonate around 10 ppm, then changing the excitation 
pulse offset to the negative side would lower the sensitivity of detecting that proton 
because the FLEX excitation efficiency would be much lower for the peak around 10 
ppm. The result for the FLEX sequence with pulse offset applied at -46.10 ppm on 
44% hematocrit, 57% oxygenated whole blood is displayed in figure 7.15B. A dataset 
acquired with the same parameters but with the pulse offset at +46.10 ppm is 
displayed in figure 7.15A for comparison. Additionally, another scan with the FLEX 
excitation pulse set to +34.57 ppm was run with all other parameters (durLTM, number 










Figure 7.15. FLEX Spectra for (A) FLEX Excitation Pulse Applied at 46.10 ppm (B) 
FLEX Excitation Pulse Applied at -46.10 ppm (C) FLEX Excitation Pulse Applied at 
34.57 ppm.  
 As expected, a peak around 10 ppm is seen in figure 7.15A, but a couple of 
aspects of figure 7.15B stand out. First, the NOE peak appears to be “larger” than the 
amide proton peak relative to figure 7.15A. This makes sense because application of 
the pulse at a negative offset frequency would give the NOE peak higher sensitivity 
because of a higher excitation efficiency (see FLEX excitation efficiency plots in 
figure 7.5). What is odd is that the peak that we originally detected around +10 ppm is 
now around -10 ppm. Furthermore, if we look to figure 7.15C where we moved the 
frequency offset at which the FLEX excitation pulse was applied closer to water, we 
would expect the peak around 10 ppm to have an even higher excitation efficiency 
than when the FLEX excitation pulse was at +46.10 ppm.  However, that peak is not 
visible. 
 Our conclusion was that the peak around 10 ppm that we imaged using FLEX 
MRI was actually a flow artifact that manifested in a phase change. If we refer to the 
exponential FLEX equation (equation 7.5), we see that φ is an important component 
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of the equation and represents the phase of the exchangeable proton that is being 
imaged. When blood (or any other sample that is imaged) is flowing, there is a phase 
change, and the phase change was being modulated in the FLEX spectrum. However, 
this explanation alone is not enough to explain the oxygenation dependence of the 
peak amplitude. Our conclusion is that the flow artifact resulted in a fold over of the 
bulk water peak. Because the T1 and T2 of blood are different for different 
oxygenations, we believe we were imaging these T1 and/or T2 differences in a fold 
over artifact.  
 Therefore, we concluded that we should stop the flow during RF preparation 
and data acquisition. We also took a closer look at the slice thickness and wondered 
whether or not RF inhomogeneities at the edge of the RF coil would cause any issues 
too. And finally, we believed that there may be baseline drift in our CEST images and 
needed a method to correct for this. Additionally, we thought that the high power of 
the saturation pulse (high B1) was saturating much of the bound proton pool (from 
erythrocyte cell membranes), and we were worried that this generated an MT effect 
that could also mask the 1-2% effect that we were interested in. 
 
7.7.  Methods – Part 2 
After realizing the issues that we faced may be hiding the signal we were interested in, 
we decided to modify our experiments. To do this, we reanalyzed our profile to reduce the 
RF inhomogeneities at the edges of the coil, and we flowed the blood in the phantom except 
during RF preparation and data acquisition. To flow blood in the phantom except during RF 
preparation and data acquisition, code was written to run in the background of the NMR 
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console synchronized with the data acquisition to instruct me when to flow the blood and 
when to stop it.  
 
7.7.1. Checking the Profile Acquisition 
 After realizing that RF inhomogeneities at the edges of the coil may be 
causing “un-clean” FLEX labeling that are flowed into the region where we were 
detecting the signal, we decided to run the following test. Before the spin echo 
acquisition, we added a single 30 µs 90° FLEX pulse to test the efficiency of the 
FLEX 90° pulse and varied the slice thickness (by varying the strength of the readout 
gradient).  
Table 7.3. Checking the Efficiency FLEX 90° Pulse versus Slice Thickness. 






It appeared that RF inhomogeneities at the edges of the coil significantly 
reduced the efficiency of the FLEX 90° labeling pulse when a 3 cm slice was used. 
Although it appears that the labeling efficiency is optimal for a 1 cm slice, we 
considered the loss in signal-to-noise ratio (SNR) with a 1 cm slice. SNR in MRI is 
directly proportional to slice thickness so a 1 cm slice would have three times less 
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SNR than a 3 cm slice. Ultimately, we decided a 2.5 cm slice maximized the signal-
to-noise ratio and sufficiently reduced inhomogeneities from the edges of the RF coil. 
 
7.7.2. Baseline CEST Spectrum Drift 
Because the signals we detect using CEST are of the order of 1-2%, it is 
important to verify that the baseline of the z-spectra has no interference from other 
sources of noise. However, similar to the human data in Chapter 6, we noticed 
instabilities in the baseline of the CEST spectra so we ran unsaturated scans 
repeatedly for 47 minutes.  
 
Figure 7.16. Drift of S0 Images at 700 MHz. 
Because of the baseline drift of unsaturated images, S0 scans need to be 
interspersed throughout the CEST acquisition to correct for this drift. Baseline drift 




7.7.3. Testing Stop & Go with FLEX Acquisition 
It is important to verify that stopping and flowing the blood does not cause 
any unwanted artifacts in the FLEX spectrum so we put 44% hematocrit whole blood, 
100% oxygenation into the perfusion system and ran FLEX scans using a flow speed 
of 0.17 mL/second and while using the Stop & Go program. Furthermore, we 
increased the exchange time (texch) to 10 ms and reduced the number of LTMs to 200 
so the total RF preparation time for FLEX remained the same (2 seconds). 
 
 Figure 7.17. Testing Stop & Go Acquisition Using FLEX 
It does not appear that the Stop&Go acquisition introduces any artifacts into 





7.7.4. Testing Stop and Go with CEST Acquisition  
Additional testing with the stop and go was also performed with CEST 
acquisitions where we flowed the blood during the pre-scan delay and stopped it three 
second before the saturation pulse was applied. We wanted to generate  
 
 Figure 7.18. Testing Stop & Go Acquisition Using CEST. 
Our data shows that the Stop & Go acquisition does not introduce any 
abnormal artifacts into the CEST spectra either.  
 
 7.7.5. CEST Acquisitions Using Stop & Go 
After verifying that flowing the blood except during RF preparation and data 
acquisition did not induce any artifacts in the CEST and FLEX spectra, we proceeded 
with acquiring data this new way. This allowed us to maximize signal-to-noise by 
imaging all of the exchangeable protons that we labeled (previously a portion of the 
protons that were labeled were flowing out). We proceeded to acquire CEST data 
with the following sequence parameters: saturation pulse duration = 5 seconds, 
saturation pulse B1 = 1.4 µT, offset frequencies acquired: -15 ppm to +15 ppm 
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(increments of 0.2 ppm), pre-scan delay = 11 seconds. Unsaturated scans (S0) were 
interspersed throughout the acquisition after every 10 frequencies acquired so 
baseline correction can be applied. This resulted in a total scan time of 44 minutes 
and 39 seconds. We also tried increasing the range at which our offset frequencies 
were acquired to -20 ppm to +20 ppm. This increased the total scan time to 59 
minutes and 37 seconds. We acquired the CEST data using a saturation pulse B1 = 1.4 
µT and 2.5 µT. 
 
7.8. Results and Discussion – Part 2 
CEST – with flowing blood EXCEPT during RF preparation and data acquisition 
After re-thinking the experiments and optimizing the necessary parameters, 





Figure 7.19. CEST spectra (top) and MTRasymmetry (bottom) of 44% hematocrit whole 
blood at 100% oxygenation (red) and 60% oxygenation (blue).  
Saturation pulse duration = 5 seconds, saturation pulse B1 = 1.4 µT. 
The CEST data in figure 7.19 shows two distinct peaks in the CEST spectra of 
the 44% hematocrit whole blood at 60% oxygenation. The peak at +13.4 ppm shows 
an effect of 3-4% with a linewidth of 0.4 ppm, and the peak at +7.6 ppm shows an 
effect of 2-3% with a linewidth of 0.3 ppm. At a chemical shift of +7.6 ppm and 
+13.4 ppm in the 100% oxygenation CEST spectra, there do not appear to be any 
peaks. Unfortunately, after running a few scans, the oxygenation of the blood could 
not be held constant and the sample had to be discarded.  
We tried to repeat that experiment at more oxygenations, however, we did not 
see the peaks that we previously saw. Results of follow-up CEST scans done with 
44% hematocrit whole blood at 58%, 70%, 90%, and 100% oxygenations with 
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saturation pulse duration of five seconds and saturation pulse B1 of 1.4 and 2.5 µT are 





Figure 7.20. Follow-up Results CEST Spectra (top) and MTRasymmetry (bottom) for  
(A) B1=1.4 µT (B) B1=2.5 µT 
There appear to be some small differences in the MTRasymmetry graphs between 
different oxygenations, but these effects are likely due to differences in T1 and T2, 
which are known to affect the direct saturation region of the CEST spectra.  
7.9. Conclusion 
In conclusion, while our initial efforts have taught us many new concepts and shown 
some interesting results for this topic, we have been unable to reproduce consistent results. 
Possible ways for improving stability includes using a motor with automatic control for 
stopping and starting flow that can be synchronized to the spectrometer or using a different 
experimental set-up with the capability of mixing blood while imaging occurs. We believe it 
should be possible to detect exchangeable protons in blood using CEST and FLEX, and a 
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Chapter 8. Conclusion and Future Directions 
 
8.1. Conclusion  
 The research described in this dissertation developed, optimized, and applied novel 
pulse sequences for imaging the ischemic penumbra in acute stroke patients. All of the work 
in this dissertation focused on magnetic resonance imaging modalities that are non-invasive 
owing to recent research showing the dangers (nephrogenic systemic fibrosis, an untreatable 
disease that at its severest stage leads to death) of using gadolinium-based contrast agents.  
In this work, we quantitatively measured blood flow in the cerebellum using 
pseudocontinuous arterial spin labeling. It was demonstrated that a shorter labeling duration 
(600 ms) coupled with shorter post labeling delays could be used to quantify blood flow in 
the cerebellum. Acquired perfusion-weighted images correspond well to co-registered 
anatomical images, and cerebellar blood flow values and transit times fitted from data 
acquired over five volunteers are in good agreement with values published in literature from 
positron emission tomography and magnetic resonance imaging.  
Next, we optimized magnetization transfer vascular space occupancy (MT-VASO), a 
cerebral blood volume weighted technique, for imaging acute ischemic stroke patients. Work 
done on this topic included modeling MT-VASO signal changes over the range of cerebral 
blood volume changes for ischemic stroke patients, testing the sequence on normal 
volunteers, and applying the sequence to elucidate changes in cerebral blood volume in 
patients. Results in three patients showed that MT-VASO localized increases in the cerebral 
blood volume of patients (due to autoregulation) with blood vessels that may not have 
collapsed yet. However, processing of this data is tedious and can be complicated by changes 
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in the longitudinal and transverse relaxation times of tissue that change in later stages of 
ischemia.  
Furthermore, recent research showing that reductions in cerebral blood flow beyond a 
certain threshold (30% of normal cerebral blood flow) causes neurons to switch from aerobic 
respiration (with oxygen) to anaerobic respiration (without oxygen) and leads to the build-up 
of lactic acid, which eventually causes tissue acidosis. We proceeded to apply pH-weighted 
imaging with CEST MRI to image the tissue acidosis, but noticed that scanner drift interfered 
with our measurements. We developed a baseline correction method for pH-weighted 
imaging based on acquiring unsaturated images interspersed within the saturated images. The 
unsaturated scans were fit with a smooth spline and the saturated images were corrected 
accordingly. This helped to reduce the noise within the CEST spectra leading to better fits 
using the Lorentzian difference method of analysis. Results from two ischemic stroke 
patients show that pH-weighted imaging could possibly predict tissue at risk of infarction 
more accurately than perfusion weighted imaging. An additional result from a third stroke 
patient (who also had stenosis in the left carotid artery) suggests that pH-weighted imaging 
may have some useful applications in carotid artery stenosis patients. 
Finally, when thinking about how to develop image methods that are sensitive to 
other parameters that change for ischemia, we began work on developing a technique that 
could show changes in oxygenation based on using CEST MRI and frequency label exchange 
transfer MRI to study exchangeable protons on hemoglobin proteins in the blood. Although 
this study has not yet been completed yet, we have performed a number of experiments and 
learned a tremendous amount of information. Preliminary data shows the possibility of 
178 
 
oxygenation dependent exchangeable protons at +13.4 ppm and +7.6 ppm downfield from 
the water peak.  
 
8.2. Future Directions 
 Much of the work in this dissertation can be continued further. We will summarize 
how some of the work mentioned in this dissertation can be carried further in the following 
bullet points: 
• For pH-weighted imaging in ischemic stroke patients, we have shown some 
promising initial results of pH-weighted imaging being a better predictor of tissue at 
risk of infarction. However, this is just the beginning. Further studies should 
systematically compare the predictive value (of tissue progressing to infarction) of 
pH-weighted imaging to perfusion weighted imaging using a receiver operating 
characteristic (ROC) curve, a plot based on correctly and falsely identifying tissue 
that will progress to infarction. 
Improvements can also be made from a sequence development perspective. 
Patient motion is always an issue especially with stroke patients given the level of 
discomfort that they feel. Recently, data acquisition methods have been developed 
and accounts for patient motion during acquisition. Tailoring such a sequence towards 
pH-weighted imaging for stroke patients would not be trivial but could be immensely 
useful in the clinic.  
• For using chemical exchange saturation transfer and frequency label exchange 
transfer to image exchangeable protons on hemoglobin, our results show that it 
should be possible to image oxygenation dependent exchangeable protons on 
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hemoglobin and use this as a way to spatially image oxygen extraction fractions in the 
brain and other areas of the body.  
In conclusion, we believe the work presented in this dissertation has made 
contributions to the area of diagnostic stroke imaging. However, exciting future work is not 
limited to the contents of this dissertation. It will also depend on the funding opportunities 
and future students/researchers’ interest. We hope more excellent research work could be 
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Neuroradiology MR Physics Seminar Series. Johns Hopkins School of Medicine. 
October 19, 2010. Invited by Dr. Richard Edden. 
 
4. Non-invasive Method to Image Cerebral Blood Volume Changes in Acute 
Ischemic Stroke Patients. Radiology MR Division Retreat, Johns Hopkins School of 
Medicine. October 8, 2010. Invited by Dr. Peter van Zijl. 
 
5. Towards Quantitative Cerebellar Blood Flow Imaging. Radiology MR Division 
Retreat, Johns Hopkins School of Medicine. October 23, 2009. Invited by Dr. Peter 




Signals and Controls Teaching Assistant (01/08-05/08 and 01/09-05/09) 
• Involved in teaching approximately 120 sophomore undergraduate students the 
fundamentals of signals and systems properties and analysis. 
• Guest lectured for professor several times throughout the semester. 
• Taught three recitation sections (20-30 students each section) each week.  
 
Digital Logic Design Teaching Assistant (01/04-05/04) 
• Assisted in teaching course material to students. 





President of JHU Biomedical Engineering PhD Council    08/09-08/10 
• Worked with professors and PhD students to develop and implement policies fair to 
both parties to accelerate the time to graduation in our department.  
• Budgeted and planned symposia, leadership training, and social events for PhD 
students in the biomedical engineering department. 
• Co-procured $10k activity budget per anum. 
 
President of JHU Taiwanese Students Association    05/07-05/08 
• Worked with the JHU International Students Office and the Taipei Economic and 
Cultural Representative Office to implement guidelines to facilitate the smooth 
transition of over 100 recently arrived Taiwanese graduate students to life in the 
United States.  







International Society for Magnetic Resonance in Medicine (ISMRM) (2008 – present) 
Order of the Engineer (2006 – present) 
Eta Kappa Nu (Electrical Engineering Honors Society) (2004 – present) 
 
SPECIAL SKILLS AND INTERESTS 
 
1. Fluent in English and Mandarin Chinese; reading knowledge of Spanish. 
2. Four years of programming experience with Philips MR machines. 
3. Six years of experience with developing MATLAB software for image processing. 
4. Five years clinical scanning experience (sickle cell patients, acute ischemic stroke, 
alcoholics, stroke recovery patients). 
5. One year of experience using and programming high resolution NMR spectrometers 
(Bruker 500 MHz horizontal and vertical bore, Bruker 700 MHz). 
6. Proficient in fMRI data analysis tools (FSL, FAST segmentation, FLIRT image 
registration, BET brain extraction tool). 
7. Proficient in Microsoft Word, Excel, PowerPoint. 
 
Vita 
 Alan Huang was born on June 29, 1984 in Redbank, New 
Jersey. He was raised by Dr. Nian Huang and Mrs. Piching 
Huang and grew up with his younger brother Bernard Huang. 
He received a Bachelors of Science in Electrical Engineering 
and a Bachelors in Science in Neurobiology in 2006 from the 
University of Texas at Austin in 2006. From there, he enrolled 
in the PhD program in the Department of Biomedical 
Engineering at Johns Hopkins University School of Medicine. 
His research interests lies in the development of novel contrast 
mechanisms with MRI. 
After obtaining his PhD in Biomedical Engineering in Professor Peter van Zijl’s lab, Alan 
will pursue a career in industry by joining Philips Healthcare in Best, Netherlands as a 
Clinical MRI Expert performing Research and Development functions within the MRI 
business unit. 
He can be reached at Alan.J.Huang@jhmi.edu. 
